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ABSTRACT 
VIRGINIA JEAN HOGLUND: Characterization of the Arterial Adventitia as a Sonic 
Hedgehog Responsive Niche 
 (Under the direction of Mark W. Majesky) 
 
While formerly viewed as merely connective tissue, the emerging view of the 
arterial adventitia is that of a complex and organized vascular progenitor cell niche. 
Previously, our lab has identified a domain of Sonic Hedgehog (Shh) signaling 
restricted to the adventitia. This domain is locally produced and maintained, with the 
peak of activity being during embryonic and neonatal development of the vessel 
from embryonic day 14.5 (e14.5) to postnatal day 14 in the mouse. Developmental 
studies suggest that the mesenchyme continuous with the perichondrium of the axial 
skeleton contains Shh responsive cells that may contribute to adventitial 
development around e14.5. The cell types that participate in this Sonic Hedgehog 
adventitial signaling community are CD68-positive macrophages, Sca1-positive 
progenitor cells, and Perilipin A-positive adipocytes that make and/or respond to Shh 
protein as shown using transgenic reporter mice. Thus, we characterize the 
adventitia as a Shh responsive vascular niche. 
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
Background 
Niche Environments 
Classic and Flexible Niche Models 
Stem cell biology and regenerative medicine are frontiers of research that are 
rapidly gaining momentum and showing promise as future therapeutics for many 
diseases including Alzheimer’s, muscular dystrophy, and repair of ischemic injury 
after myocardial infarction. Important in understanding the nature of stem cells is 
characterizing the specialized microenvironments that prevent their differentiation 
and promote their survival called niches. A niche is defined to be a “subset of tissue 
cells and extracellular substrates that can indefinitely house one or more stem cells 
and control their self-renewal and progeny production in vivo” (Figure 1)1. There are 
two types of niches: a classic niche and a “flexible” niche. The Drosophila ovary is a 
model system that contains both types of niches for the three types of stem cells 
involved in oogenesis. The germline stem cells (GSCs) and escort stem cells are 
maintained in classic niches, while the follicle stem cells (FSCs) reside in a flexible 
niche 2, 3. 
Classical niches consist of differentiated cells that directly contact stem cells 
and direct their self-renewal and behavior (Figure 1A)2, 4. In the fruit fly Drosophila 
2 
 
melanogaster, the ovary, known as the “germarium” was first described as a classic 
niche for the germline stem cells (GSCs) by Xie and Spradling in 20005. In the last 
decade of research, data suggest that there are two key mechanisms that promote 
functionality of this classical niche: adhesive interactions between the niche cells 
and stem cells and asymmetric signaling6.  
In contrast, follicle stem cells (FSC) reside in a “flexible” niche where the 
architecture and position of the niche is less clearly defined (Figure 1B)3. In such 
niches, there are no obvious differentiated support cells to provide an anchoring 
function. Instead the stem cells generate some of the components necessary for 
their self-renewal and maintenance2, 3, 7. Specifically, FSCs in the germarium 
produce the essential local niche component, Laminin A, which activates integrin 
signaling in the FSC, promoting anchoring and proliferation of the cell3. Additionally 
required, differentiated niche resident cells (red and blue, Figure 1B) secrete 
paracrine signals to the FSCs (green, Figure 1B) to stimulate proliferation. In one 
example, niche resident cells produce the ligand Hedgehog (Hh) to signal to FSCs 
that express its receptor Patched (Ptc) and effector proteins Smoothened (Smo) and 
the Drosophila homolog of transcription factor Gli, Cubitus Interruptus (Ci)8, 9. 
Mutants for Hh, Smo, or Ptc all have defects in FSC proliferation rates, indicating an 
important role for the pathway in control of FSC proliferation8, 10.   
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Figure 1: Schematic of two types of niches. A) A classical niche: Adhesive 
factors (light blue) keep the stem cells (green) inside the niche to reinforce 
paracrine signals from niche cells (blue) that block differentiation. When stem 
cells divide, they can either divide symmetrically to make 2 stem cells (upper 
mitotic cell) or they can divide asymmetrically (lower mitotic cell) and produce 
a stem cell and a differentiated daughter (red). Figure adapted from Spradling 
et al.1 B) A flexible niche: Stem cells (green) receive paracrine factors from 
niche resident cells (blue, red) but also produce autocrine factors for self-
maintenance. Integrin signaling is one mechanism stem cells use to adhere to 
the ECM (brown and grey lines) and maintain position in the niche. 
 
The Perivascular Niche 
In vertebrates, there are several examples of perivascular spaces as being 
important for nurturing stem cells. One example is the neural progenitor niche in the 
brain. Neurons, astrocytes, and blood vessels are organized in functional 
“neurovascular units” in which the vasculature can impact neuronal activity and, in 
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turn, dynamically adjust to its change11. Recent work by Licht et al. shows that 
vascular endothelial growth factor (VEGF) is important for neurogenesis. Transgenic 
mice with tet inducible expression of VEGF in the brain increased angiogenesis and 
neurogenesis in the hippocampus and improved memory. Once tetracycline was 
removed and the overexpression was turned off, neurogenesis was still improved 
over controls, although memory regressed back to control levels11. The authors 
speculate that the expanded vasculature provided an expanded niche for neuronal 
stem cells in the VEGF on>off mice11.  Additionally, Kokovay and colleagues show 
that proliferative subventricular zone (SVZ) neural progenitor cells home to 
endothelial cells in a stromal-derived factor 1 and CXC chemokine receptor 4 
(CXCR4)-dependent manner, making cell-cell contact with the vessel, and laying 
down long processes along its length12. These studies suggest that the vasculature 
provides an important niche environment for neuronal precursors. 
Hematopoietic stem cells have also been shown to be maintained in a 
perivascular niche. Rafii et al. showed that bone marrow derived endothelial cells 
(ECs) co-cultured with hematopoietic stem cells (HSCs) produced several 
hematopoietic cytokines that promoted proliferation and differentiation of the HSCs13, 
14. Davis et al. went on to show that ECs from the porcine brain microvasculature 
were capable of expanding HSCs in culture, suggesting that ECs from non-
hematopoietic tissues could also support HSC growth in vitro15. Subsequent studies 
confirmed that human brain endothelial cells produced soluble factors that induced a 
10 fold expansion of HSCs from cord blood and bone marrow in vitro16-18. 
Collectively, these studies suggest an important function for the bone marrow 
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vasculature, particularly the ECs, in regulating hematopoiesis and hematopoietic 
regeneration. 
In the mammalian testis, it has recently been shown that spermatogenic stem 
cells are localized to the vasculature. Yoshida and colleagues performed 
experiments using time lapsed confocal imaging of GFP tagged spermatogenic stem 
cells that showed that the stem cells stayed close to the vessels and migrated away 
as they differentiated19. Furthermore, experimental alteration of the vasculature 
resulted in rearrangement of the stem cells19. While the stem cells did not directly 
touch the vasculature, they were in close proximity, and clustered with macrophages 
and Leydig cells, a testis support cell thought to be derived from pericytes. The 
researchers speculate that these perivascular cells take part in producing this niche 
by production of androgens and other necessary factors19. It is also possible that the 
vessels secrete soluble factors that the spermatogenic stem cells require for 
maintenance, and unlike the gonads in flies, tight junctions with the niche cells are 
not required. 
 
The Arterial Adventitia 
Structure and Function 
The tunica adventitia has been long thought of as a simple layer of collagen-
rich connective tissue matrix embedded with a few fibroblasts and perivascular 
nerves (reviewed in Majesky, 2011 20 and Majesky, 2012 21). This definition is fast 
becoming outdated as research is now discovering that the adventitia is a complex, 
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organized, and diverse community of cell types that serve important functions in the 
wall, and support a progenitor cell niche20-31.  
Functionally, the adventitia serves as a dynamic compartment for cell 
trafficking into and out of the vessel wall, and adventitial cells play key roles in artery 
wall growth, control of lumen size by remodeling the extracellular matrix, opposing 
the transmural pressure to prevent overdistension of vessel, and defense against 
infection32-34. This layer of artery wall also contains a microvasculature, called the 
vasa vasorum, which penetrates and nourishes the medial and intimal layers of the 
artery wall32, 35. Adventitial microvessels from the vasa vasorum extend through the 
media and into atherosclerotic plaques where they serve as important channels for 
leukocyte trafficking into and out of the lesion36, 37. Recent studies describe novel 
and interesting roles for the adventitia insofar as it supports resident stem cell 
antigen-1 (Sca1)-positive progenitor cells that can adopt both vascular and non-
vascular cell fates20-31. The molecular pathways that maintain vascular progenitor 
cells in the adventitia, that promote the growth of adventitial microvessels, and that 
coordinate overall growth and remodeling of the adventitia during development and 
the postnatal period have not been described. 
The structure of the adventitial matrix has recently been reported in the 
porcine coronary artery34. The researchers found that both the collagen and elastin 
fibers formed alternating layers in the inner adventitia. In the outer adventitia, elastin 
fibers were largely absent, and collagen fibers were randomly arranged compared to 
the inner adventitia. This is consistent with an earlier report examining the elastin 
composition of the adventitia in the canine aorta that found alternating lamellae of 
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collagen and elastin fibers in the adventitia38. These reports suggest a level of 
organization to the adventitia and a role in structural support of the wall. 
 
Figure 2: Schematic of the artery wall. The adventitia is home to 
progenitor cells (AdvSca1, green), a diverse array of leukocytes (blue, 
pink, grey, light green), perivascular nerves and their support cells 
(yellow-green and brown), fibroblasts (purple), the vasa vasorum 
(orange), and its supporting adipose tissue and pericytes (yellow, dark 
purple, respectively) all embedded in a collagen and elastin rich 
extracellular matrix (grey and brown lines). Int = intima, Med = media, 
Adv = adventitia, IEL = internal elastic lamina, EEL = external elastic 
lamina 
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Adventitial Progenitor Cells 
Adventitial progenitor cells were first described in work by Hu et al.23. They 
sought to find a source of progenitor cells in ApoE knockout mice. By staining many 
types of non-bone marrow tissues for a panel of stem cell markers, they found that 
the arterial adventitia was the only location where significant numbers of cells 
expressing these markers could be found. These cells expressed Sca1, c-kit, CD34, 
and Flk1, but lacked embryonic stem cell marker SSEA-123. To test the in vivo 
potential of these cells, they isolated genetically labeled cells from Rosa26 donor 
mice and transplanted them into wild type mice on the outside of an experimental 
vein graft. After 4 weeks, the genetically labeled cells were found to have migrated 
through the media into the graft neointima, and had become smooth muscle marker 
positive and Sca1-negative. In the control experiment, Sca1-negative adventitial 
fibroblasts from Rosa26 donor mice did not leave the graft adventitia, and were only 
rarely found in the neointima23. In vitro experiments confirmed the ability of Sca1 
cells to differentiate into smooth muscle in response to PDGF-BB23. In this model, 
adventitial Sca1 cells were shown to be able to differentiate into SMCs and 
contribute to neointimal formation20. 
There have been several reports since then that have found similar results. 
Work by Campagnolo et al. isolated CD34-positive cells from human saphenous 
veins of patients undergoing cardiac bypass surgery39. These cells expressed the 
stem cell marker Sox2 and exhibited multilineage potential. Furthermore, the when 
transplanted into a mouse hindlimb after ischemic injury, these human CD34-
positive cells differentiated into pericytes that formed N-cadherin mediated contacts 
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with endothelial cells and enhanced angiogenesis that promoted recovery in the 
ischemic limb39. 
 
Figure 3: Vascular progenitor cells. Sca1-positive progenitor cells 
reside in the adventitia, and form highly organized layers and clusters 
with each other20. 
 
Work by Passman and colleagues further characterized the adventitial niche 
and AdvSca1 cells by describing a novel domain of Sonic Hedgehog (Shh) signaling 
restricted to the adventitia25. Passman and colleagues concluded that Shh was 
involved in survival and proliferation of the AdvSca1 cells.  In vivo, Shh knockout 
mice had significantly reduced, but not absent, numbers of AdvSca1 cells. In vitro, 
treatment of AdvSca1 cells with the Hh signaling inhibitor cyclopamine showed 
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reduced proliferation and survival with no increase in apoptosis20, 25, 40. They 
confirmed results by Hu et al. that AdvSca1 cells differentiated into SMCs in vitro, 
and further showed that roughly half of these cells readily differentiated into SMCs in 
culture after removal from the adventitial niche with only the addition of serum to the 
culture medium and no additional growth factors23, 25. This observation that AdvSca1 
cells differentiate into SMCs in response to serum was also made by Howson et al. 
examining spheroid forming rat adventitial cells41.  
Passman et al. went on to confirm that this SMC population occurred because 
of differentiation and not proliferation of contaminating SMCs by treatment with 
aphidicolin, an inhibitor of cell division. Further examination of these cultures 
revealed roughly ¼ of the cells retain their Sca1 phenotype, and the remaining ¼ 
lose Sca1 expression but do not detectably express smooth muscle markers20, 25, 40. 
These data suggest that AdvSca1 cells are a heterogeneous population of cells with 
different potentials (See figure 19 for model).  Indeed, culturing isolated AdvSca1 
cells from Rosa26 mice in Matrigel plugs containing recombinant FGF2 and heparin 
injected subcutaneously in the mouse showed these cells can differentiate into 
pericytes, adipocytes, and macrophages40 (Supplementary figure 1).  
 
Molecular Control of Progenitor Cells 
Much current research is being conducted on the molecular and epigenetic 
control of stem and progenitor cells and their self-renewal and differentiation. 
Smooth muscle progenitors in particular are governed by the actions of key 
transcription factors including serum response factor (SRF), co-activators like 
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myocardin, and co-repressors like Krüppel-like factor 4 (Klf4) (reviewed in Xiao, 
2010 42).  
SRF is a MADS-box containing transcription factor, comprised of a DNA 
binding element, a dimerization domain, and an interface for protein-protein 
interaction43. Smooth muscle genes contain one or more of the binding sites for SRF 
called CArG elements, with a CC [A/T]2 A [A/T]3 GG motif, in the promoter or intronic 
sequence44. Because SRF is not specific for smooth muscle, interactions with co-
activators and co-repressors provide regulation and control over target genes. Some 
influence SRF binding to DNA45, while others form a complex with SRF to either 
stimulate (myocardin related factors, Csrp1) or inhibit (Klf4 46, Msx1 and 2 47, Elk1 48) 
transcriptional activity. Also important to the regulation of SRF-mediated 
transcription is the actin cytoskeleton. Myocardin related factors bind to G-actin and 
are released into the nucleus to interact with SRF during Rho-activated actin 
polymerization and treadmilling49. Upstream activators of SRF and myocardin 
activity include TGFβ50, PDGF42, and Wnt251. 
Repressors of SRF-mediated transcription include factors like Foxo4: a 
transcription factor that represses the activity myocardin52; and Klf4: a transcription 
factor that inhibits the expression of myocardin and possibly recruits histone 
deacetylases to modify chromatin structure at smooth muscle genes44, 46. Klf4 has 
recently come on stage as one of the four transcription factors that reprogram 
fibroblasts into pluripotent stem cells53, 54.  Passman and colleagues showed that 
AdvSca1 cells express both Foxo4 and Klf4, and upon removal from the adventitial 
niche, AdvSca1 cells downregulated Klf4 expression and upregulated smooth 
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muscle marker genes25. Knockdown of Klf4 by siRNA enhanced differentiation of 
AdvSca1 cells into SMCs, and overexpression of Klf4 by adenoviral infection 
inhibited differentiation in response to serum40. The factors released by the niche to 
promote and regulate expression of Klf4 to maintain AdvSca1 cells have not yet 
been determined. 
Chromatin remodeling is an important aspect of transcriptional regulation in 
all cell types, especially stem/progenitor cells. Studies of differentiation of HSCs into 
erythrocytes showed the importance of higher order chromatin structure and 
chromatin looping of the β-globin locus control region to interact with a downstream 
promoter by Brg1, a component of the SWI-SNF chromatin remodeling complex55.  
Also, it has been shown that various stimuli known to alter SMC phenotype, such as 
TGF-β, PDGF, and retinoic acid, appear to act in part through effects upon SMC 
chromatin structure56. Also, as stated above, Klf4 has been implicated in recruiting 
deacetylases to modify acetylated histone H4, a histone modification that is 
associated with open chromatin44. Understanding the chromatin landscape of 
AdvSca1 cells may be important in deciphering the mechanisms for self-renewal and 
regulation of differentiation. As it is likely that AdvSca1 cells are a heterogeneous 
population of progenitors, chromatin marks and higher order structure may differ 
from cell to cell in the overall population, and identification of markers of 
subpopulations within the AdvSca1 total population would benefit an analysis of the 
chromatin landscape of these cells.  
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Aging and Progenitor Cells: Dysregulation of the Niche 
Progenitors from old and young mice do have intrinsic differences. For 
example, telomerase is less active in “old progenitors” than “young progenitors”, 
leading to shortened telomeres and eventually proliferative senescence. Old satellite 
cells have reduced notch signaling, which reduces their capacity to self-renew57. 
Hepatic progenitors gradually increase expression of cEBPα and chromatin-
remodeling factor brahma over time and are less capable of regeneration of the 
aged liver58. However, recent studies suggest that loss of function of niche-
dependent signaling may be a contributing factor of various pathologies associated 
with aging, including greying and loss of hair, fibrosis, kyphosis, mal-absorption of 
nutrients, and osteoporosis59-64.  
Studies show that exposure of “old” progenitors to a “young” niche enhances 
proliferative capacity and increases their ability to regenerate. Transplanting muscle 
from a two year old mouse into a two month old mouse and then injuring the tissue 5 
weeks later resulted in increased expression of embryonic myosin heavy chain, 
BrdU incorporation, and regeneration of damaged muscle than in two year old 
muscle transplanted into another two year old mouse65. This phenomenon has also 
been seen in liver parabiosis experiments65. 
In a mouse model of premature aging, Fox et al. reported that there was a 
ten-fold increase in apoptosis in the intestinal crypts of 3-7 month old mice, primarily 
in the progenitor cell zones, resulting in impaired ability to absorb excess fat when 
placed on a high fat western diet chow64. Stem cell-derived organoids from these 
mutant mice failed to develop fully in culture and exhibited fewer crypt units, 
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indicating a dysregulation of intestinal progenitor cell maintenance64. While these 
mice do carry a mitochondrial mutation that impairs editing function of mitochondrial 
DNA synthesis, it would be interesting to see how much of this phenotype is due to 
the mutant prematurely aged niche and how much is inherent in the mutant stem 
cells by transplanting intestinal crypt cells from mutant mice into age matched wild 
type mice and vice versa. 
Reduction of adventitial progenitor cell pools with aging or mutation has not 
been directly tested, but may be a contributing factor to medial dissection and 
aneurysm formation in the aorta. It may also predispose patients with diseases like 
scleroderma or the premature aging syndrome progeria to loss of microvasculature 
in the vasa vasorum and adventitial fibrosis61, 66. As AdvSca1 progenitor cells and 
the critical signaling provided by the adventitial niche are better characterized, age 
related degeneration and pathological changes to the artery wall due to aging can be 
targeted for therapeutic intervention21.  
 
The Adventitia in Disease and Injury 
In addition to fibroblasts and the above mentioned progenitor cells, the 
adventitia is home to several leukocyte cell types including tissue resident CD68-
positive macrophages, T-cells, B-cells, and mast cells67-70. Although the functions of 
these cells have not been described in non-pathogenic settings, several studies 
have implicated adventitial lymphocytes participating in inflammation and remodeling 
in injury and disease models. George Tellides’s lab showed that depletion of 
macrophages prevented flow-dependent inward remodeling in the mouse carotid71. 
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Their lab went on to show that inward remodeling of the mouse carotid artery in 
response to reduction in blood flow required early adventitial accumulation of 
CXCR3-positive macrophages. They found evidence that a subset of macrophages 
with high levels of CXCR3 accumulated in the adventitia undergoing remodeling, 
suggesting an expansion of a population already resident, homing of monocytes with 
this gene expression profile, or both72.  
In another study of flow mediated remodeling, Erami and colleagues found 
that catecholamines had a significant effect on the inward and outward remodeling in 
response to changes in flow73. Ligation of the left carotid artery branches causes a 
reduction in flow in the left carotid and an increase in flow in the right carotid. In wild 
type mice, these changes in flow mediate an inward remodeling of the left carotid 
and outward remodeling in the right carotid. In the left carotid, this is accompanied 
with increases in the size of the adventitia, with increased proliferation, increased 
apoptosis, and as stated above, increase in macrophage accumulation73. These 
effects are inhibited in knockout mice of dopamine β-hydroxylase (DBH), the enzyme 
that synthesizes epinephrine and norepinephrine. Catecholamines have been shown 
to regulate Shh signal in lung morphogenesis74. Knockout mice of α2B-AR, an 
adrenoceptor, die right after birth of respiratory failure. These mice show strong 
upregulation of Shh, leading to an overproliferation of mesenchymal cells in the lung, 
reducing alveolar space74. It is possible that Shh is also increased in the adventitia of 
the DBH knockout mice with the reduction of catecholamine signaling. It would be 
interesting to test this hypothesis, and determine if an increase in Shh signal 
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reduces the hyperproliferative and inflammatory effects of flow dependent 
remodeling of the artery wall.   
Additionally, adventitial macrophages have been shown to respond to infusion 
angiotensin II (Ang II), a vasopressor known to promote vascular inflammation. 
Infusion of Ang II into 7 to 12 month old C57Bl6/J mice caused adventitial expansion 
and recruitment of macrophages to the adventitia. Adventitial cells in these mice 
produced inflammatory cytokines IL-6 and MCP-1, leading to the development of 
aortic dissection in some mice, a condition where the inner layers of the aorta tear, 
and blood begins to force the layers apart; a frequently fatal condition if not 
surgically repaired75. The researchers went on to show that the IL-6 and MCP-1 
produced in the adventitia promoted differentiation of monocytes into macrophages, 
and stimulated production of matrix metalloproteinase 9 (MMP9) and MCP1 by 
adventitial fibroblasts, creating an amplification loop that accelerated inflammation75. 
The production of these cytokines was 2.3 fold greater in vitro when adventitial 
fibroblasts were cocultured with monocytes over either cell type alone75, 76. These 
data suggest there is a paracrine signaling relationship between different adventitial 
cell types and provide further support for the importance of the adventitia  as a 
mediator of inflammatory cell interactions that can initiate physiological flow-
dependent remodeling as well as the pathological remodeling of the artery wall20. 
Another example of adventitial leukocytes playing a role in vascular 
remodeling comes from a study examining the role of T-cells and B-cells in 
hypertension. The researchers found that RAG knockout mice that lack both T-cells 
and B-cells have a blunted response to infusion of Ang II: a factor that produces 
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hypertension in wild type mice. Adoptive transfer of T-cells, but not B-cells, restored 
the wild type hypertensive response77. Infusion of low doses of Ang II stimulated 
production of chemokines by the vessel wall that recruited T-cells to the adventitia 
and peri-adventitial adipose tissue77. These T-cells became activated and produced 
inflammatory cytokines like TNFα, INFγ, and p47phox. These cytokines stimulate 
superoxide production that reduces the amount of available nitric oxide in the vessel 
wall, and increases smooth muscle contractile tone20, 77. These studies highlight the 
important role of the adventitia as a site of T-cell homing and activation in disease.  
Other arterial injury models have reported to have an effect on the adventitia. 
It has been shown that endothelial denudation by balloon injury not only induced 
neointimal formation, but also increased the fibroblast number and collagen 
deposition in the adventitial layer78. Furthermore, removal of the adventitia from 
rabbit carotid arteries results in formation of a hyperplastic intimal lesion79. This 
lesion regresses when a “neoadventitia” is grafted over the site of injury unless the 
animal is fed a high cholesterol diet79. Similarly, removal of rat abdominal aortic 
adventitia shows an initial severe trauma of the endothelial surface leading to 
complete de-endothelial areas as early as six hours after injury and intimal 
hyperplasia as early as one month after injury80. The researchers in both of these 
studies suggested that this response was likely due to the removal of adventitial 
microvessels and the ensuing hypoxia in the artery wall.  
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The Hedgehog Signaling Pathway 
Drosophila hedgehog (Hh) was discovered in 1980 by Nusslein-Volhard and 
Wieschaus81. Since then, the hedgehog pathway has come to the forefront as a 
major player both in embryonic development and disease. Hh signaling has been 
implicated as a mitogen controlling proliferation and promoting cell survival82-84, a 
repressor of cell differentiation in progenitor cells85, an angiogenic factor86-90, and as 
a morphogen controlling cell fate in a dose dependent manner91-94. Research into 
blocking Hh signaling is a promising therapeutic for many cancers95, 96, as well as 
some anti-psychotic medicines97, so new data are constantly being added to the 
picture and evolving our understanding of this highly regulated and complicated 
signaling network. Key components of the pathway and regulation are discussed 
below. 
 
The Vertebrate Hedgehog Signaling Pathway 
The vertebrate hedgehog family consists of three secreted ligands- sonic 
(Shh), indian (Ihh), and desert (Dhh) hedgehog94. While all three bind the receptor 
Patched (Ptc) with similar affinity, these three hedgehog proteins have differing 
expression patterns and exert functional effects with different potencies. 
Knockout mice of each of these genes reveal very different phenotypes. Shh-/- 
is embryonic lethal with about half of the expected number of embryos surviving to 
term, and none surviving beyond birth98. These mice have defects in numerous 
systems including craniofacial, spinal cord, limb, lung, skeletal, and patterning of the 
outflow tract of the heart98. Ihh-/- is also embryonic lethal, with similar survival rates 
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as Shh-/-. Ihh-/- embryos primarily have skeletal defects92. Mutants display markedly 
reduced chondrocyte proliferation, maturation of chondrocytes at inappropriate 
positions, forelimb and rib shortening, and failed development of osteoblasts in 
endochondral bones92. Unlike the other two, Dhh-/- is not lethal. Mice are viable, but 
with fertility defects, as spermatogenesis is impaired99. 
All three hedgehog ligands are produced in a similar fashion. As a specific 
example, Shh is synthesized as a ~45 kDa pre-protein that is autocatalytically 
processed into a ~19 kDa N-terminal domain (Shh-N) and a ~25kDa C-terminal 
domain (Shh-C) by activity intrinsic to the C-terminal domain100. Shh-C further 
processes Shh-N by adding a cholesterol residue to its C-terminus. Additional lipid 
modification of Shh-N results in a palmitoyl moiety added to the N terminal 
Hedgehog domain by the acetyltransferase skinny hedgehog (Ski)101-103. These lipid 
modifications facilitate the integration of Hh into multimeric lipoprotein particles94, 104. 
The release of this complex from the producing cell is dependent on the activity of 
Dispatched 1 (Disp1)105. Harfe and colleagues created a knockin mouse that is able 
to genetically label cells that are actively producing Shh using an EGFP-cre fusion 
protein under the control of the Shh locus (ShhEGFP) by examining localization of 
EGFP91; an important tool used in the work described in chapter 2. 
Hh signaling is initiated through binding to its receptors Patched-1(Ptc1) and 
Patched-2 (Ptc2) and to their accessory proteins CDO, Gas1, and BOC, which 
potentiate signaling106-108. In the absence of ligand, patched represses the activity of 
a signal transducing protein called smoothened (smo). Smo proteins contain a 
conserved sterol sensing domain and current evidence suggests that ptc represses 
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Hh signaling by transporting smo-activating sterols out of the cell84. In the absence 
of activated smo, the gli family of transcriptional mediators of Hh signaling is 
processed to a repressive form. This occurs when full length Gli (Gli-FL), bound to 
the inhibitor suppressor of fused (sufu)109, is phosphorylated by protein kinase A 
(PKA), glycogen synthase kinase 3β, (GSK3β), and casein kinase 1 (CK1)110-114. 
This multi-phosphorylated Gli-FL is then recognized by βTrCP, in complex with an 
E3 ubiquitin ligase114. Gli-FL is polyubiquitinated and marked for partial degradation 
by the proteasome to the truncated and repressive form (Gli-R). 
The gli family of zinc finger transcription factors includes members gli1, gli2, 
and gli3. Gli1 primarily has an activator function, and no reported repressive ability. 
Gli3 is primarily a repressor, with weak activator function. In an unusual mechanism, 
the proteasome processes Gli3 in the absence of Hedgehog pathway stimulation 
while Gli1 is not processed but degraded completely, despite considerable homology 
with Gli3115. These differences in processing can be described by defining a 
processing signal that is composed of three parts: the zinc finger domain, an 
adjacent linker sequence, and a degron. Gli1 is not processed because two 
components of the processing signal, the linker sequence and the degron, are 
ineffective115. Gli2 is a composite of positive and negative regulatory domains and 
functions as both an activator and repressor. In cultured cells, truncation of the 
activation domain in the C-terminal half results in a protein with repressor activity, 
while removal of the repression domain at the N-terminus converts Gli2 into a strong 
activator116.  Studies have described a “Gli code”, where the cell’s response to Hh 
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signal is determined by the combination and relative levels of the three Gli factors, 
and the balance of their full length active forms and truncated repressor forms117, 118. 
Shh binding to Ptc1 inhibits sterol transporter activity, thereby allowing 
activating sterols to accumulate to levels that activate Smo84. Activated Smo then 
traffics to the primary cilium where critical signal mediators (Gli 1-3 and Sufu) are 
concentrated119, 120. Activated Smo antagonizes the effects of Sufu, an inhibitor of 
Gli. Data currently indicate this occurs by way of two kinases. Uncoordinated51-like 
Kinase 3 (Ulk3) phosphorylates Gli-FL, and STK36 phosphorylates Sufu121-123. This 
results in processing of Gli-FL proteins (Gli1-3) to their transcriptionally-active forms 
and Shh-dependent gene expression is stimulated. Importantly, several Hh pathway 
elements are also targets of Shh signaling including ptc1, ptc2, and gli1, so 
transgenic mice with the LacZ gene under the control of these promoters are used 
as sensitive reporters of Shh signaling in vivo.(Ptc1LacZ/+, Ptc2LacZ/+, and Gli1LacZ/+ 
respectively) These reporter mice as used as tools in specific aims 1 and 2. 
Regulation of Hh signaling is mediated by several factors. SPOP is an 
important regulator of activated Gli. SPOP complexes with Cul3 ubiquitin ligase to 
recognize Gli-A in the nucleus and mark for proteosomal degradation109, 114, 124. As 
activated Gli 1-3 have a wide variety of targets like growth factors and morphogenic 
factors that could potentially be dangerous in the event of prolonged activity, it is 
essential to keep tight control over the half-life of Gli-A, and thus SPOP provides a 
necessary mechanism of regulation over hedgehog signaling. 
Heparin sulfate proteoglycans are components of the ECM that are also 
involved in regulation of Hh signaling. HSPGs can bind to the secreted Hh ligand 
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and have been shown to be involved in setting up gradients of Hh, and propagating 
the Hh signal over long distances. Recent work suggests that the HSPG perlecan is 
also required for maximal activation of Shh, especially in the brain125. 
 
 
Figure 4: Schematic of mammalian hedgehog signaling.  In the 
absence of Hh ligand, Gli transcription factor (Gli 2,3) is processed to a 
repressor form (Gli-R) by successive phosphorylation by PKA, GSK3β, 
and CK1. This phosphorylated form is recognized by βTrCP as part of 
an E3 ubiquitin ligase complex with Cul1. Conversely, Gli (Gli 1-3) is 
23 
 
activated when Hh is present to promote transcription of target genes, 
including Hh pathway elements ptc1, ptc2, gli1, and gli2. 
 
The Primary Cilium 
The primary cilium is a crucial component of transmission of vertebrate Hh 
signal, unlike in Drosophila. Once regarded as a mere curiosity, the primary cilium is 
widely becoming known as an organelle implicated in coordinating and regulating 
many different signaling pathways, including Hh, Wnt, and PDGF126-130. 
Inappropriate assembly of the primary cilium results in a whole class of disorders 
called ciliopathies, examples being Bardet-Biedl syndrome, Meckel syndrome, 
Joubert syndrome, and both the recessive and dominant forms polycystic kidney 
diseases131.  
Primary cilia consist of an axoneme of nine doublet microtubules that extends 
from a basal body, which is derived from the centriole132. In contrast to those of 
motile 9+2 cilia, axonemes of primary cilia lack the key elements involved in motility, 
including the central pair of microtubules, the proteins that surround them, and the 
dynein arms that power microtubule sliding to produce motility133, 134. The axoneme 
itself is assembled by the intraflagellar transport proteins, including the kinesin and 
dynein motors that power transport132. Knockouts of many of the IFT proteins result 
in absent or blunted primary cilia, leading to aberrant hedgehog signaling130, 135-137. 
Genetic studies show that IFT proteins act somewhere downstream of Ptc and Smo 
and upstream of the Gli transcription factors 1-3, and are thought to be involved in 
Gli processing114, 138. 
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The first evidence that vertebrate Hh signaling depends on primary cilia came 
from a screen for ENU-induced mutations that alter the patterning of the mouse 
embryo119, 130. This screen identified several mutants showing morphological and 
patterning defects that were phenotypically consistent with disrupted Hh signaling. 
The genes disrupted in these mutants encode several components of the IFT 
machinery, including the IFTB complex components IFT122, IFT172 and IFT88, and 
subunits of the retrograde and anterograde motors DynC2H1 and Kif3a136, 139.  
Despite the evolutionary conservation of the Hh pathway and the importance 
of primary cilia in vertebrate Hh signaling, cilia are not required for Hh signaling in 
Drosophila. This raises the question of why cilia are required for vertebrate Hh 
signaling. Recent data suggest that Kif7, a kinesin that is the vertebrate homologue 
of Drosophila Costal 2, may link the vertebrate Hh pathway to cilia130, 140-142. Cos2 is 
a kinesin-related protein that serves as a scaffold for Hh signaling complexes. Cos2 
is required for formation of the repressor form of the Drosophila Gli homologue Ci by 
recruiting the kinases that mark Ci for processing. Cos2 is also required after 
pathway activation to promote maximal pathway activation by antagonizing Sufu130. 
Although Cos2 can bind microtubules, its motor domain has diverged from other 
kinesins such that its motor function is disabled143. The vertebrate homolog Kif7 has 
similar function as Cos2. It is required for the processing of Gli3 to its repressor form 
in the absence of Hh and also required for the efficient localization of Gli3 to cilia in 
response to Hh signaling activation. However, unlike Cos2 the Kif7 motor domain 
has the motifs that are typical of kinesin motors. In the absence of ligand, Kif7 
localizes to the base of the primary cilium and moves to the tip in response to 
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pathway activation130, 142. This translocation depends on the motor domain, which 
suggests that Kif7 acts as an anterograde motor141, 142. These results cumulatively 
suggest that Cos2/Kif7 are an evolutionary link between Hh and primary cilia.  
Furthermore, recent work in planaria suggests that some conserved 
components of the Hh pathway were associated with cilia before they were 
associated with Hh. RNAi knockdown of Fused, Cos2, and Iguana, known Hh 
signaling components in flies and zebrafish, resulted in worms with a reduction in 
cilia, but intact Hh signaling144. Knockdown of known planarian IFT components had 
similar results144. Based on these findings, the authors concluded that cilia are not 
required for Hh signaling in planarians, and that the ancestral function of Fused, 
Cos2 and Iguana is in the regulation of ciliogenesis132, 144.  A related study, which 
focused on the planarian iguana gene, also arrived at similar conclusions145. These 
data provide insights as to why Hh signaling requires primary cilia in vertebrates but 
not in lower animals. 
 
Hedgehog Signaling and the Vasculature 
In vascular development, Hh is required for arterial-venous specification of 
endothelial cells146, 147, angiogenesis in the murine yolk sac148, as well as the 
remodeling of branchial arch blood vessels90. It is also a potent angiogenic factor87, 
89, 149. Blocking hedgehog signaling drastically impairs angiogenesis in both the 
neural tube150 and retina151 while overexpression in the neuroectoderm causes 
hypervascularization85. Mechanistically, it has been shown that Shh regulates the 
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expression of FGF, VEGF, and angiopoietin 1 and 2 in fibroblasts88, 89, 152, 153: all 
potent angiogenic factors.  
Other studies suggest a direct effect of Shh on endothelial cells154, 155. 
Renault et al. found that non-canonical Hh signaling in endothelial cells through the 
Rho pathway led to EC migration, capillary morphogenesis, and upregulated 
expression of matrix metalloproteinase 9 and osteopontin, important matrix 
remodeling factors required for angiogenesis155. A similar study also found that Shh 
induced capillary morphogenesis of ECs in vitro. The researchers found that Shh 
upregulated phosphoinositide 3 kinase (PI3K) and Shh induced morphogenesis was 
abolished when cells were treated with a PI3K inhibitor154. 
 
Hedgehog Signaling and Progenitor Cells 
One important function of Shh is promoting maintenance and survival of 
progenitor cells. Several studies have shown that Hh signaling is required in various 
regions of the brain to stimulate proliferation of progenitors and promote their 
survival. Conditional deletion of Shh or Smo in the telencephalon showed reduced 
progenitor cell numbers in the hippocampus and subventricular zone in the postnatal 
mouse brain156. Conversely, reactivation of Shh signaling in the mature brain 
resulted in an increase in proliferation of telencephalic progenitors156. In the 
cerebellum, Shh is required for proliferation of granule cell progenitors157-159. Ectopic 
expression of Shh in the spinal cord expanded neural progenitor cells and prevented 
their differentiation, reminiscent of tumors of the CNS85. Fate mapping Shh 
responsive cells using an inducible cre under the control of the Gli1 promoter shows 
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that Hedgehog responsive cells in the brain self-renew and while normally quiescent 
become mitotically active in response to injury160.  
Shh has also been implicated in the maintenance and proliferation of 
progenitors in several other niches. Liver progenitor cells are marked by PtcLacZ/+ 
activity. When treated in vitro with Hh inhibitor cyclopamine, these cells become 
apoptotic161. In the hair follicle there is a niche for stem cells that contribute to the 
cycling hair follicle as well as epidermal cells upon injury. These cells are Gli1LacZ/+ 
positive, and receive Shh from nearby nerves. Upon denervation, the stem cells in 
the upper bulge region of the niche are unable to make epithelial stem cells that 
contribute to wound healing. Their ability to contribute to the hair follicle was 
unaltered, possibly due to a source of Dhh at the base of the follicle162. A similar 
study found roles for Shh and Dhh in epidermal stem cell maintenance163. 
Overexpression of either in the epidermis produced embryos that either had 
hyperplastic stem cells or a loss of self-renewal, suggesting an importance for 
balance of Hh signal in stem cell maintenance163. Smooth muscle progenitor cells in 
the developing ureter have also been shown to rely on Shh signal. Shh promotes 
mesenchymal cell proliferation, regulates timing of differentiation into SMCs, and 
sets the pattern of differentiation through dose-dependent inhibition of smooth 
muscle formation82. In the absence of Shh signal, smooth muscle mass is greatly 
reduced due to a proliferation defect, and the progenitor cells are largely absent82. 
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Macrophages and the Vasculature 
Macrophages have been implicated in angiogenesis, especially in hypoxic 
environments. Recent studies have correlated angiogenesis with HIF2 expression 
in tumor associated macrophages in human breast cancer164, 165. These tumor 
associated macrophages release proangiogenic growth factors including VEGF and 
fibroblast growth factor (FGF)166. Microarray data also implicates the upregulation of 
more than 30 proangiogenic genes in primary macrophages exposed to hypoxia, 
including angiopoietin, IL-8, VEGF receptor 1, and inducible form of nitric oxide 
synthase (iNOS)167.  
Furthermore, recent studies show that ablation of macrophages 
pharmacologically from aortic explants blocked angiogenesis in vitro. This ability was 
restored when exogenous macrophages were added to the culture168. Enhanced  
capillary sprouting in aortic rings by co-culture with macrophages was not dependent 
on cell-cell contact between the ECs and macrophages, as conditioned medium 
from macrophages had the same stimulatory effect169.  
Interestingly, a recent study provided evidence that macrophages played a 
key role in the development of the vascular plexus in the mouse brain, retina, and 
zebrafish trunk. Their data suggest that macrophages guide tip cells together to form 
an anastomosis170: an important process in increasing the complexity of the plexus. 
 
Hedgehog Signaling In Macrophages and Inflammatory Cells 
Macrophages, mast cells, T cells, and other lymphocytes are all residents of 
the adventitia of normal vessels67, 171. Adventitial macrophages may play important 
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roles in the progression of intimal lesion formation in atherosclerosis. One study 
found that upon progression of atherosclerosis in apolipoprotein-E-deficient mice, 
there was a significant increase in the total number of macrophages, T-cells, and 
dendritic cells in the adventitia, suggesting that atherosclerosis induces the 
recruitment of inflammatory cells67. 
Cells of the immune system show evidence of Hedgehog signaling. Myeloid 
cells (CD33-positive), B cells (CD19-positive), T cells (CD3-positive) and primitive 
progenitors (CD34-positive CD38-) express ptc, smo, and shh mRNA83, 172-174. 
Monocyte derived macrophages express the hedgehog pathway components ptc, 
gli1, gli2, and smo. It has also been shown that macrophages upregulate expression 
of ptc in response to stimulation by commercially available recombinant Shh175. 
Recent evidence shows that macrophages use Shh as a chemoattractant to a 
gastric infection176.  Deletion of Shh from the parietal cells or deletion of Smo from 
macrophages resulted in a decrease of inflammation and macrophage recruitment to 
the stomach in response to infection with the bacterium H pylori176. 
 
Adipocytes and the Vasculature 
Adipose tissue is one of the most highly vascularized tissues in the body, with 
each adipocyte encircled by microvessels177. Indeed, emerging data show that 
angiogenesis modulators affect the expansion of fat mass by regulating the growth 
and remodeling of the adipose associated vasculature178. Vascular beds can also 
influence the growth of adipose tissue by a number of other mechanisms. For one, 
activated endothelial cells in angiogenic vessels produce growth factors that 
30 
 
communicate to the adipocytes in a paracrine manner to produce mitogenic 
effects177. Additionally, a recent study has shown that vascular pericytes can be 
differentiated into preadipocytes and adipocytes179. 
Conversely, adipocytes can influence the growth and remodeling of the 
vasculature. Many adipokines (cytokines produced by adipocytes) are also 
angiogenic; an example being Leptin180. More than 40 adipokines have been 
identified so far. 
 
Hedgehog Signaling and Adipocytes 
Hedgehog has been implicated in adipocyte biology as a negative regulator of 
white adipose differentiation181. However, this study further showed that brown 
adipocytes are unaffected by overexpression of Hh signal and develop normally. 
Adipocytes surrounding the thoracic aorta are largely brown adipocytes182. It is yet to 
be determined whether Hh is required for brown adipocyte formation.  
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Specific Aims 
This research was conducted towards the overall goal of characterizing the 
arterial adventitia as a Shh responsive vascular niche. We hypothesize that Shh is a 
key factor maintaining and/or developing this niche, and so we sought to answer the 
questions of what other cell types participate in Shh signaling in this environment 
that may be key niche cells, and when this niche forms in development. 
Specific aim 1: Determine the cell types involved in Shh signaling in the adventitia 
that contribute to making the adventitial niche. 
Specific aim 2: Determine the time the adventitia first appears in the embryo and 
characterize its spatial development, using responsiveness to Shh as a 
marker. 
  
  
 
CHAPTER 2 
SONIC HEDGEHOG SIGNALING IN THE NEONATAL ARTERIAL ADVENTITIA 
Introduction 
The adventitial layer of the artery wall has long been considered merely inert 
connective tissue. Recent evidence suggests that it is an active participant in flow 
dependent wall remodeling71, 76, 80, 183, 184, a site for immune cell accumulation and 
activation in injury and disease67-69, 72, 75, as well as an active niche for progenitor 
cells that can adopt both vascular and non-vascular fates22, 24, 25, 27, 28, 30.  
Our previous work identified a novel Shh signaling domain restricted to the 
adventitial layer of the artery wall25. Our data suggest that a paracrine Shh signaling 
network is involved in maintaining a progenitor cell niche in the adventitia. To begin 
to identify roles that Shh signaling plays within the artery wall, it is first necessary to 
identify the cell types that produce Shh in the adventitia, and then to determine what 
cell types are actively responding to it.  
Shh signaling is an essential morphogen, mitogen, and survival factor in 
many contexts including development and cancer94, 185. Shh has been shown to be 
required in survival and proliferation of progenitor cells in the brain156, 160, liver161, 
hair follicle162, 163, and ureteral smooth muscle82. 
In vascular development, Shh is required for arterial-venous specification of 
endothelial cells through the repression of venous cell fate146, 147, angiogenesis in 
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the murine yolk sac148, as well as the remodeling of branchial arch blood vessels90. It 
is also a potent angiogenic factor87, 89, 149. Blocking hedgehog signaling drastically 
impairs angiogenesis in both the neural tube150 and retina151 while overexpression in 
the neuroectoderm causes hypervascularization85.  
 
Hypothesis 
Shh signaling plays a role in developing and maintaining the adventitial niche 
through paracrine interactions between adventitial progenitors and other 
differentiated adventitia resident cells.  
 
Materials and Methods 
All antibody and reagent product numbers and sources are listed in Appendix B. 
Mice 
All animal protocols were approved for use by the Institutional Animal Care 
and Use Committees of the University of North Carolina and Seattle Children’s 
Research Institute. All mouse strains used were obtained from the Jackson 
Laboratories. Noon on the day of vaginal plug was designated as day 0.5. The day 
of birth was designated as P0. Mice used include Ptc1LacZ/+ (Ptch1tm1Mps, Jackson 
stock number: 003081)186, Ptc2LacZ(Ptch2tm1Dgen, Jackson stock number: 005827)187, 
Gli1LacZ/+ (Gli1tm2Alj, Jackson stock number: 008211)188, Gli2LacZ/+ (Gli2tm2.1Alj, Jackson 
stock number: 007922)189, and ShhEGFP/+ (B6.Cg-Shhtm1(EGFP/cre)Cjt Jackson stock 
number: 005622)91. See Appendix C for strain specific genotyping information. See 
Appendix D for mouse strain information.  
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Whole Mount Immunostaining 
ShhEGFP/+, Ptc1LacZ/+, and Gli1LacZ/+ mice were sacrificed at postnatal day 2, 
perfused with PBS to clear the blood, and arterial tissues were then fixed at 
physiologic pressures with 4% PFA at 100 mmHg. Thoracic aortas and carotid 
arteries were dissected, post fixed in 4% PFA for 30 minutes at room temperature, 
and then rinsed with PBS for 15 minutes. Antigen retrieval methods vary based on 
the primary antibody used. Antibodies against intracellular proteins like SMαA are 
retrieved with a 15 second wash in methanol. Antibodies against nuclear proteins 
and primary cilia are retrieved by adding 0.1% Triton X 100 to the blocking solution 
(2% normal donkey serum (NDS) + 2% normal goat serum (NGS) + 0.1% bovine 
serum albumin (BSA) in PBS). No antigen retrieval is used when staining for cell 
surface proteins like Sca1. See appendix B for list of antibodies and dilutions and 
notes on antigen retrieval conditions. 
Samples were blocked at room temperature with blocking solution composed 
of 2% NDS + 2% NGS + 0.1% BSA in PBS for one hour. Primary antibody was 
diluted in blocking solution overnight and incubated at 4⁰C. Samples were rinsed in 
PBS for 15 minutes, and blocked again at room temperature for 1 hour in recycled 
blocking solution. Secondary antibody diluted in 0.1% BSA in PBS was applied to 
the tissue for 2 hours at room temperature. Samples were then rinsed in PBS for 15 
minutes. Hoechst dye (Molecular Probes) was diluted to 1μg/ml in H2O, and applied 
for 1 minute. Tissue samples were washed briefly in H2O, followed by a brief wash in 
PBS before storage in a 1:1 glycerol: PBS solution at 4⁰C. Samples can be stored in 
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these conditions for several months to a year protected from light with no loss of 
signal. Samples were imaged on a Zeiss LSM5 Pascal Confocal Laser Scanning 
Microscope, an Olympus FV500 Confocal Laser Scanning Microscope, an Olympus 
FV1000 Confocal Laser Scanning Microscope, or a Leica SP5 Confocal Laser 
Scanning Microscope.  
Sections immunohistochemically stained for ECM components were 
processed by the histology core facility at Benaroya Research Institute at Virginia 
Mason, Seattle, WA.  
 
FITC Dextran Injection 
Mouse pups were anesthetized with 5% isoflurane in 1000cc oxygen, and 
anesthesia was maintained using 2% isoflurane in full oxygen.  A midline incision 
was made in the chest, and pectoral muscles were reflected to visualize the heart 
through the intercostal muscles. Pups were injected through the left ventricle with 
50μl of 20mg/ml solution of high molecular weight FITC-Dextran (2000kDa) (Sigma). 
Dextran was allowed to circulate for 5 minutes before euthanizing the animal.  
 
EdU Injection 
Mouse pups were given 100μl of 0.3mg/ml EdU in sterile 0.9% NaCl by IP 
injection (50mg/kg). After 2 hours, mice were sacrificed and fixed with 4% PFA. 
Staining was done according to the manufacturer’s instructions (Invitrogen). 
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Xgal Staining 
Tissues were fixed using 0.2% gluteraldehyde solution in a 0.1 M sodium 
phosphate buffer pH 7.3 containing 2 mM MgCl2 and 5 mM EGTA for 1 hour at room 
temperature. Samples were then washed three times for 30 minutes at room 
temperature with rinse buffer pH 7.3 containing 0.1 M sodium phosphate, 2 mM 
MgCl2, and 0.1% Triton X100. Finally, tissue samples were stained overnight in a 
shaking incubator at 37°C using X-gal staining buffer pH 7.3, composed of 5 mM 
potassium ferricyanide, 5 mM potassium ferrocyanide, 0.02 M Tris-Cl, and 1 mg/ml 
Xgal (Bioline) diluted in the rinse buffer described above. Tissue samples were post-
fixed in 4% PFA for 30 minutes at room temperature and stored in PBS. Whole 
mount X-gal stained tissues were imaged on a Leica MZFLIII stereomicroscope with 
the Leica DFC310FX camera. 
 
Results 
Shh Responsive Cell Types in the Arterial Adventitia 
Our studies using Ptc1LacZ/+, Ptc2LacZ/+, and Gli1LacZ/+ transgenic reporter mice 
and cell type-specific antibodies have identified several key players involved in Shh 
signaling in the adventitia. These reporter mice are a useful because Ptc1, Ptc2, and 
Gli1 are not only mediators of hedgehog signaling, but also direct Shh target genes, 
and serve as reporters of active hedgehog signaling186-188. We were initially 
surprised to find that the expression of the reporters was entirely restricted to the 
adventitia25(Figure 5). No other signaling pathway that we are aware of has been 
shown to be confined exclusively to the arterial adventitia. When using cell type 
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specific antibodies, we observe that cells expressing -galactosidase (-gal) in the 
Hedgehog reporter mice included CD68-positive macrophages and Perilipin A-
positive adipocytes in the aorta or carotid arteries from newborn mice. These cells 
cluster with AdvSca1 progenitor cells, indicating possible paracrine signaling 
between these cell types. 
 
 
Figure 5: Hedgehog responsive cells in the adventitia. PtcLacZ/+ and 
Gli1LacZ/+ expression is restricted to the adventitia. X-gal stained P0-P2 
aorta sections, counterstained with nuclear fast red (A, B). CD68-
positive macrophages (D, F, arrowheads), and adipocytes (G, I, double 
arrows) express both Ptc1LacZ/+ and Gli1LacZ/+. AdvSca1 cells cluster 
with cells strongly positive for Ptc1LacZ/+ and Gli1LacZ/+ (C, E). Primary 
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cilia are also localized solely to the adventitia, marked by acetylated α 
tubulin (H, J, arrows).  
 
We also detect that these -gal-positive cells have primary cilia, which are 
marked by acetylated α-tubulin (Figure 5 H, J). Primary cilia are required proper 
processing and activation of Gli transcriptional mediators 1-3130. We also observe 
that these β-gal-positive cells express the co-receptor BOC (Figure 6B). Previous 
work has shown that the overall population of AdvSca1 cells expresses RNA 
transcripts for Smo, BOC, CDO, Ptc1, Ptc2, Gli1, and Gli225. While AdvSca1 cells do 
not appear to express Ptc1LacZ/+ or Gli1LacZ/+, a couple of them appear to express 
BOC. These data support and confirm the findings from reporter mouse data. 
 
 
Figure 6: Immunostaining for Shh pathway elements confirms reporter 
mouse data. A small subset of AdvSca1 cells (arrow in A) and 
Ptc1LacZ/+-positive cells co-localize staining with Hedgehog co-receptor 
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BOC. Arrowheads in A: BOC strongly positive cells that 
morphologically resemble tissue resident macrophages. Arrowheads in 
B: BOC-positive and Ptc1LacZ/+-positive cells that morphologically 
resemble macrophages. Arrow in A: colocalization of Sca1 and BOC. 
Not all AdvSca1 cells also express BOC. Arrows in B: cells with 
nuclear localized LacZ that also co-express BOC. These cells cannot 
be identified by morphology. 
 
We also observe that Hedgehog responsive cells are organized in the 
adventitia into layers and clusters (Figure 7). This architecture and arrangement of 
cells is similar to the organization we observe for AdvSca1 cells (Figure 3 B, C) and 
may reflect the overall structure of the adventitial ECM as described in porcine and 
canine vessels34, 38. We hypothesize that this clustering behavior is important for 
AdvSca1 maintenance. Adherens junctions and cell-cell mediated contacts have 
been shown to be important in maintaining stemness in niches7, 190, 191. This 
clustering effect may also be important in regulating the level of Shh signal. Shh has 
been shown to induce different fates in a dose dependent manner, so clustering and 
layering may be in part to ensure the cells participating in the paracrine signaling 
loop are receiving the proper amount of Hh ligand91, 192, 193. It has been shown that 
the inner adventitia is composed of alternating layers of collagen and elastin fibers in 
the pig and dog34, 38. These reports suggest a level of organization to the adventitia, 
and this ECM organization likely mediates the layering of cells in the adventitia. 
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Figure 7: Hedgehog responsive cells in the neonatal adventitia are 
organized into clusters and layers. In the early postnatal aorta, 
Hedgehog responsive cells are distributed throughout the adventitia in 
layers and clusters. Images were taken of a side profile of whole mount 
vessels.  
 
 
Figure 8: Gli2LacZ/+ expression in the artery wall. Gli2LacZ/+ is expressed 
in both the media and the adventitia in the early postnatal period, and 
medial expression persists into adulthood. 
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 One curious observation we note is that Gli2LacZ/+ does not have a similar 
staining pattern to the Hedgehog reporters shown in Figure 5. In Ptc1LacZ/+, 
Ptc2LacZ/+, and Gli1LacZ/+, we repeatedly observe that Hedgehog signaling is restricted 
entirely to the adventitia, and never have we observed any staining in the media, in 
embryogenesis, perinatal development, or adulthood. Gli2LacZ/+ mice have abundant 
and strong expression both in the media and adventitia. This suggests that Gli2LacZ/+ 
expression is uncoupled from a dependency on Shh signaling in the artery wall. It is 
likely that Gli2 is being transcribed in response to a pathway other than Shh. A 
recent study found that Gli2 and Gli3 are transcribed in response to Notch1 signaling 
in neural progenitors194. It has also been shown that Gli2 is a transcriptional target of 
TGF-β signaling195, 196. Both of these pathways have been shown to be active in 
vascular SMCs to promote differentiation50, 197, 198. Further study will be required to 
determine the mechanism for Gli2 transcription in the medial smooth muscle cells. 
 
Shh Production in the Arterial Adventitia 
Expression of the Hedgehog reporters Ptc1, Ptc2, and Gli1 in the adventitia 
led to the next obvious question, is Shh protein produced locally, and if so, from 
which cell types? To address this question, we studied early postnatal mice from 
another reporter strain, ShhEGFP/+. This mouse has EGFP knocked into the 
endogenous Shh locus, and serves as a faithful reporter of cells actively producing 
Shh91. Previous work from our lab demonstrated that Shh protein concentrated along 
the border between the media and adventitia (Figure 10D)25. The source of this Shh 
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protein was unclear. In the analysis shown in Figure 9, adventitial cells producing 
Shh are identified by anti-EGFP using whole mount confocal microscopy. The data 
suggest that Shh is synthesized locally and that the protein we detected between the 
medial and adventitial layers was made by adventitial cells themselves. We 
observed that EGFP-positive cells are numerous in the postnatal day 1 (P1) 
adventitia (Figure 9) and like PtcLacZ/+, EGFP expression also was restricted 
exclusively to the adventitia, with no smooth muscle cells in the media expressing 
either EGFP or Shh protein. Cell types that we observed to be strongly EGFP 
positive include CD68-positive macrophages, nerves marked by β-tubulin III, and 
Sca1-positive adventitial progenitor cells (Figure 9). About half of the Perilipin A-
positive adipocytes stain with Shh-antibody, and weakly stain with ShhEGFP/+. We 
confirmed these results by immunostaining with anti-Shh (DSHB) (for antibody 
information, see Appendix B). The 5E1 Shh antibody developed by Thomas Jessel 
and Susan Brenner-Morton was obtained from the Developmental Studies 
Hybridoma Bank developed under the auspices of the NICHD and maintained by 
The University of Iowa, Department of Biology, Iowa City, IA 52242. 
Some of these results are consistent with previous reports on Hedgehog 
signaling in similar cell types, but not all. Shh has been shown to be expressed in 
cells of the immune system. Myeloid cells (CD33-positive), B cells (CD19-positive), T 
cells (CD3-positive) and primitive progenitors (CD34-positive CD38-) express ptc, 
smo, and shh mRNA83, 172-174. Additionally, nerves have been shown to express Shh. 
Nerve derived Shh supports stem cells in hair follicles. Upon denervation, the stem 
cells in the upper bulge region of the hair follicle niche are unable to make epithelial 
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stem cells that contribute to wound healing162. Retinal ganglion cells also express 
and secrete Shh. Interference with Shh signaling in the retinal ganglion cells 
themselves causes abnormal growth and navigation of contralateral projecting 
axons, indicating cell autonomous signaling199. Additionally, genetic cell fate 
mapping results show that Shh is exclusively expressed in all spiral ganglion 
neurons in the cochlea and not in surrounding glia cells200.  
Cell types that have not been reported to secrete Shh that we have identified 
include the Sca1-positive progenitors and adipocytes. Several studies have shown 
that stem cells respond to Shh156, 163, 201, but there is very little literature on 
progenitor cells expressing Shh. Passman et al. showed that AdvSca1 cells express 
shh mRNA25, but no other reports that we know of have stated this. Additionally, it 
has been shown that Hedgehog acts as a negative regulator of white adipose 
differentiation181. Brown adipocytes are unaffected by overexpression of Hh signal 
and develop normally181. Adipocytes surrounding the thoracic aorta are largely 
brown adipocytes182. It is yet to be determined whether Hh is required for brown 
adipocyte formation, or if brown adipocytes make Shh. 
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Figure 9: Shh is locally produced in the adventitia. AdvSca1 cells (A, 
double arrows), some Perilipin A-positive adipocytes (B, arrows), 
CD68-positive macrophages (C, arrowheads), and β-tubulin III-positive 
nerves (D, double arrowhead) all make Shh as seen by reporter 
activity. Locally produced Shh protein is localized along the 
adventitia/media border (B). 
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Because there are Shh producing cells throughout the adventitia and yet Shh 
protein is concentrated along the media-adventitia border (Figure 9B, Figure 10A), 
we hypothesized that the locally produced protein is sequestered along this border 
due to heparin sulfate proteoglycans (HSPG) and other matrix proteins in the ECM 
that Shh binds to. Perlecan is one such HSPG reported to bind Shh protein125. 
Perlecan knockout cells have an impaired ability to respond to Shh compared to wild 
type125. Indeed, we see that Perlecan is robustly expressed in the media in adult 
mice, and in the matrix in the innermost layer of the adventitia (Figure 10B). Note the 
distribution of Shh (Figure 10D) resembles the distribution of Perlecan in the inner 
adventitia (Figure 10B). 
 
 
Figure 10: ECM expression in the adult artery wall. Shh is distributed 
along the media/adventitia border (D). We hypothesize that the 
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distribution pattern is controlled by the localization of ECM proteins that 
bind Shh protein. The HSPG Perlecan is robustly expressed in the 
media and the innermost layer of the adventitia (B). Hyaluronic Acid 
(A) and Versican (C) are expressed in the adventitia and intima. Panel 
D is modified from Passman et al.25.  
 
Shh and the Vasa Vasorum 
The adventitia and particularly the periadventitial adipose tissue contains a 
microvascular network called the vasa vasorum. In the perinatal period of 
development, these microvessels are rapidly expanding, particularly within the 
rapidly growing perivascular adipose tissue. Immunostaining for anti-phospho-
histone H3 or Ki67 show a large number of dividing endothelial cells. Many 
endothelial cells in the adventitial microvasculature also incorporate EdU, a 
thymidine analog, into their DNA within 2 hours, indicating active DNA synthesis 
(Figure 11F).  
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Figure 11: The vasa vasorum. Adventitial microvessels are rapidly 
growing during the perinatal time period as shown by phospho-
histoneH3 and Ki67 staining, and EdU incorporation in a 2 hour pulse. 
Microvessels also closely associate with Shh responsive cells.  
 
We also observe that microvessels reside in a Shh rich matrix (Figure 11A) 
and closely associated with hedgehog responsive cells, as seen in the Ptc1LacZ/+ and 
Gli1LacZ/+ reporter mice (Figure 11B, Figure 12). We identify these hedgehog 
responsive cells to be CD68-positive and LysMcre/+-positive tissue resident 
macrophages (Figure 12). Macrophages have been shown to play a role in 
anastomosis in the cerebral vasculature170. Macrophages have also been implicated 
in angiogenesis in hypoxic environments, specifically tumors. Tumor associated 
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macrophages release proangiogenic growth factors including VEGF and fibroblast 
growth factor (FGF)166. Microarray data also implicates the upregulation of more 
than 30 proangiogenic genes in primary macrophages exposed to hypoxia, including 
angiopoietin, IL-8, and iNOS167. We hypothesize that macrophages are playing a 
role in angiogenesis of the vasa vasorum, and that hedgehog signaling in 
macrophages may be important in this process.  
 
 
Figure 12: Macrophages associate with the vasa vasorum. A-C: 
postnatal day 3 aortas (P3) were whole mount immunostained for 
PECAM and β-galactosidase in Ptc1LacZ/+ mice. Cells strongly positive 
for β-gal (most likely CD68-positive macrophages) are closely 
associated with adventitial microvessels (See Figure 11B). D-F: 
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postnatal day 3 aortas were whole mount immunostained for PECAM 
and anti-GFP in LysMcre/+/R26RYFP/+ mice. Macrophages positive for 
YFP immunostaining are closely associated with PECAM positive 
microvessels in the adventitia. 
 
Discussion 
Hedgehog Reporter Signaling in the Adventitia 
The basic structure of the mammalian artery wall is well established at the 
time of birth. However, a period of very rapid growth and structural remodeling of 
major elastic arteries occurs during the first two weeks after birth. For example, the 
number of SMCs in aorta of the rat increases 2.5 fold, the thickness of the wall 
doubles, there is a 3 fold increase in collagen and elastin, and smooth muscle 
protein mass amasses correspondingly in the first month after birth202, 203. These 
changes in wall structure are adaptations to large increases in blood flow and blood 
pressures that occur in tandem with the growth of the animal during the first two to 
four weeks after birth. After three months of age, growth of the artery wall is 
completed, cell proliferation rates are low, and wall structure has reached an adult 
state. Passman et al. showed Ptc1lacZ/+ activity in the aortic adventitia was highest 
from postnatal day 1 (P1) to P10, and diminished thereafter, thus correlating with 
rapid growth of all layers of the aorta including the adventitia during the perinatal 
period25. Gli1LacZ/+ expression however, does not diminish with age and reporter 
activity remains high throughout the adult life of the animal. 
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The mechanism for why Gli1 continues to be robustly expressed in adulthood 
is still unclear. One study reported similar results that Ptc1 and Gli1 were 
differentially regulated. In a mouse model of pancreatic cancer, the researchers 
reported that during tumor progression, expression of Shh and Ptc1 decreased while 
Gli1 expression remained unchanged. Gli1 levels are still high, even with the 
ablation of Smo in the pancreatic epithelium, suggesting an uncoupling of Gli1 from 
canonical signaling. They went on to show that Gli1 was regulated by TGF-β and 
KRAS in this tumor model204. Further evidence shows that Gli1 may differ from other 
Hh reporter genes due to regulation by Hh-independent mechanisms. Other studies 
have implicated regulation of Gli1 by TGF-β. In the developing lung, knockout of 
TGF-β-receptor II in the mesoderm led to upregulation of Ptc1 and Gli1, with no 
discernible change in levels of Shh205. Dennler et al. reported that TGF-beta induces 
the expression of Gli1 and Gli2 in various human cell types, including normal 
fibroblasts and keratinocytes, as well as various cancer cell lines. According to their 
results, Gli2 induction by TGF-β is rapid, independent from Hh receptor signaling, 
and requires a functional Smad pathway. Gli1 expression is subsequently activated 
in a Gli2-dependent manner195. Other studies have reported negative regulation of 
Gli1 by Notch194, 206. Notch target Hes1, a negative regulator, binds Gli1 at the first 
intron, and may prevent transcription. In a model of glioblastoma, inhibition of Notch 
with γ-secretase inhibitors increased levels of Gli1 and activated Hh signaling206. 
Non-canonical signaling of Hedgehog pathway elements is a potential mechanism to 
account for our results. To test this, it would be informative to treat Gli1LacZ/+ adult 
mice with TGF-β receptor inhibitors and examine levels of Gli1LacZ/+ expression. 
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Spatially, the distribution of Ptc1LacZ/+, Ptc2LacZ/+, and Gli1LacZ/+ expression 
patterns are not discernibly different. The adventitias of all large arteries are strongly 
positive, veins stain weakly, and lymphatic vessels are devoid of expression. 
Arteries as small as 18μm in diameter show expression of Gli1LacZ/+ in the brain, 
mesenterics, uterus, hindlimb, and heart (Supplemental Figure 5). The hedgehog 
response reporter that differs in its expression pattern from these three is Gli2LacZ/+. 
Gli2LacZ/+ is expressed in both the adventitia and the media, while all other reporters 
of Hh activity never show staining in the media.  
Gli2 has been reported to act as both a repressor and activator207, 208. In the 
absence of Hh ligand, Gli2 and Gli3 are processed to a truncated repressor form. 
When Hh signaling is activated, Gli1-3 are processed to the active form. A recent 
study has found that the proteasome processes Gli3 in the absence of Hedgehog 
pathway stimulation while Gli1 is completely degraded115. Gli1 is not processed 
because two of the three components of the processing signal are ineffective115. 
While this study did not focus on Gli2, it has been shown that Gli2 is a composite of 
positive and negative regulatory domains and functions as both an activator and 
repressor, similar to Gli3. In cultured cells, truncation of the activation domain in the 
C-terminal half results in a protein with repressor activity, while removal of the 
repression domain at the N-terminus converts Gli2 into a strong activator116.  It is 
possible that the SMCs in the media are transcribing Gli2 in the absence of Hh 
signal as a constitutive repressor, while the adventitia is using Gli2 as an activator. 
The Gli2LacZ/+ reporter mice will only be able to determine whether or not the gene 
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was transcribed. β-galactosidase will not be processed like Gli2 protein will, so we 
cannot use it as a readout of protein translation or protein modification.  
. It is likely that Gli2 is being transcribed in response to a pathway other than 
Shh. It has been recently reported that Gli2 and Gli3 are transcribed in response to 
Notch1 signaling in neural progenitors194. It has also been shown that Gli2 is a 
transcriptional target of TGF-β signaling195, 196. Both of these pathways have been 
shown to be active in vascular SMCs to promote differentiation50, 197, 198. Further 
study will be required to determine the mechanism for Gli2 transcription in the medial 
smooth muscle cells. 
There are a few possible experimental approaches to address this question. 
For one, it would be informative to do a western blot for Gli2 comparing the media to 
the adventitia. The repressive form of Gli2 is truncated, and will therefore produce a 
band that is a smaller size than Gli2-activator form. Additionally, ChIP-chip or ChIP-
seq analysis would show binding targets for Gli2. These data would then be 
compared to gene expression data with RT-PCR for these targets to show whether 
Gli2 was acting to turn on or off these targets.  
The limitation to these approaches is that they all rely entirely on a good 
antibody for Gli2. An antibody free approach to this question would be to make a 
mouse with a tagged Gli2. Epitope tagging Gli2 on the activator end would allow for 
biochemical approaches listed above to be performed with antibodies against the 
epitope tag. Additionally, a construct with different fluorescent tags (i.e. GFP and 
DS-Red) on both ends of Gli2 would allow visualization of which form of Gli2 was 
present in the cell type. Truncation of the activation domain in the C-terminal half 
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results in a protein with repressor activity, while removal of the repression domain at 
the N-terminus converts Gli2 into a strong activator116. If DS-Red were on the N 
terminus while GFP were on the C-terminus, Gli2 would be green when in its 
activated form, and red when in its repressive form based on cleavage of the protein.  
It would also be informative to look at relative levels of Gli3 between the 
media and adventitia. Gli3 has most often been described as having the strongest 
repressive activity, and having the weakest activator function117. We predict that the 
tunica media would have higher levels of Gli3 than the adventitia, and that Gli2 and 
Gli3 are acting as repressors in SMCs to keep Hh signaling off. For the same 
reason, we would expect levels of Hedgehog Interacting Protein (Hhip) to be higher 
in the media than adventitia. Hhip is a target gene of Shh signaling, and acts as a 
negative regulator by competing for binding of Hh ligand with Ptc, but not 
transmitting a signal209, 210. 
 
Next Steps 
A necessary next experiment is to verify whole mount confocal staining data 
with other methods like flow cytometry. There are many advantages to using whole 
mount confocal imaging in studying the adventitia. It shows the native architecture, 
and cell-cell physical interactions like clustering that are occurring, and individual 
cells are more clearly identified than in tissue sections. One disadvantage to this 
technique is that it is easy to misinterpret signals that are coming from 2 cells 
stacked on top of each other in the Z plane as co-localization of signal. It will be 
important to verify co-localization of cell-type specific markers with Hh reporters 
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using single cell dispersion techniques like flow cytometry. We can also adhere 
freshly isolated adventitial cells from reporter mice in single cell suspension to a 
coverslip with poly-L-lysine coating for immunofluorescence analysis.  
Another important next step for understanding the role for Shh signaling in the 
adventitia is to identify target genes in each cell type. Shh has a broad range of 
targets, and it will be important to identify key factors for establishing and 
maintaining the adventitial niche. Starting with adventitial CD68-positive 
macrophages, we will isolate these cells by immunomagnetic selection or FACS. We 
will then isolate RNA for gene expression analysis by RT-PCR and microarray. 
These data will help identify candidates for potential niche factors. Candidate genes 
will most likely be secreted factors, as there are minimal cell-cell contacts between 
AdvSca1 cells and macrophages. These cells do cluster together, but do not appear 
to be binding to one another. Gene Ontology will help identify common functions of 
genes expressed in the CD68-positive cells, as well as gene expression patterns 
that mimic other well characterized cell types. These tools will be useful in identifying 
the factor or factors produced by the macrophages that support niche function. 
In addition, we will culture these isolated macrophages and collect the 
conditioned culture medium. The conditioned medium will be used to treat isolated 
and cultured AdvSca1 cells to see if it suppresses differentiation compared to 
unconditioned medium. We can also subject the conditioned culture medium to 
ELISA analysis to look for the presence of the soluble factors found in the gene 
expression study.  
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Important variables to control in each of these experiments will be the age of 
the mice that we collect the macrophages and AdvSca1 cells from and the oxygen 
tension in the culture conditions. Because of the differences in expression of 
Ptc1LacZ/+ in newborn versus adult mice, cells from these mice are going to have 
different gene expression profiles. Because AdvSca1 cells persist into adulthood and 
are not only around during the time of PtcLacZ/+ expression, it will be important to 
examine both time points to identify genes that are only expressed during 
development of the wall, and distinguish them from genes that are involved in 
maintaining homeostasis of the niche throughout the life of the animal.  
Oxygen tension in culture conditions of both macrophages and AdvSca1 cells 
will be important to monitor as well. It has been shown that stem and progenitor cells 
are sensitive to oxygen levels and many stem cell niches are more hypoxic than 
surrounding areas211-213. While the vasa vasorum provides oxygen to the adventitia, 
oxygen levels in the adventitia are 10 mmHg lower than the endothelium of the 
normal rabbit aorta, although not the most hypoxic region of the wall214. In vitro 
culture conditions will likely be more hyperoxic than the adventitia in vivo, and will 
undoubtedly affect results. To remove oxygen tension as a variable from our culture 
conditions, it would be most effective to measure the partial pressure of oxygen in 
the mouse adventitia, and use that oxygen level in our culture conditions. If this is 
not possible, we will need to test both hyperoxic and hypoxic conditions to determine 
the effect of oxygen on our in vitro results. 
Additional future directions are discussed in the following chapters. 
  
  
 
CHAPTER 3 
SONIC HEDGEHOG IN THE DEVELOPMENT OF THE ARTERIAL 
ADVENTITIA 
Introduction 
Much progress has been made in discerning the genetic and molecular 
pathways that govern vascular development. However, the majority of the work has 
been made towards understanding the early steps in vasculogenesis, arterial-
venous specification, and patterning of the vasculature20, 21, 215, 216, while studies 
toward elucidating the origins and development of the adventitia have been lacking. 
As a broad outline, vasculogenesis begins when vascular progenitor cells, called 
angioblasts, are specified by bFGF and BMP4 signaling in the primitive streak. 
These cells form blood islands that self-assemble into a primitive vascular plexus217, 
218. A complex remodeling process ensues, and a functional embryonic circulation is 
formed from the newly fledged network of small arteries, veins, and lymphatic 
vessels 20, 218-220. Closely following the remodeling of the endothelial plexus, smooth 
muscle cells and pericytes begin to invest in the wall (Supplemental Figure 2). 
Interactions between the endothelial cells and smooth muscle cells through the 
Notch signaling pathway and biomechanical stimulation from blood flow promote 
maturation of both cell types20, 221, 222. However, there is a gap in information 
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between these early steps in the development of the media and the mature 
multilayered vessel wall complete with adventitia. 
Since the adventitia is only recently coming to light as an important niche 
environment, it is not surprising that little attention has been paid to its development. 
The goal in undertaking this work was to lay a foundation for future studies on 
origins of the adventitia and discerning the properties of the cells that live there. 
Knowing the context for how the cells came to reside in the adventitia, we can gain 
some insight into why they stay, and the factors involved in the maintenance of this 
critical niche. Additionally, understanding how an organ functions and develops 
normally can point to potential mechanisms for disease when these processes are 
misregulated or reactivated inappropriately. 
 
Hypothesis 
Shh plays a role in the development of the arterial adventitia and that 
response to hedgehog is a non-exclusive marker for cells predefined to be 
adventitia. Tracking these cells, we can observe the developmental timing and 
morphogenetic movements of the adventitia as it develops. 
 
Materials and Methods 
All antibody and reagent product numbers and sources are listed in Appendix B. 
Mice 
All animal protocols were approved for use by the Institutional Animal Care 
and Use Committee of the University of North Carolina and Seattle Children’s 
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Research Institute. All mouse strains used were obtained from the Jackson 
Laboratories. Noon on the day of vaginal plug was designated as day 0.5. The day 
of birth was designated at P0. We used Gli1LacZ/+ (Gli1tm2Alj/J, Jackson stock number: 
008211)188, and ShhEGFP/+(B6.Cg-Shhtm1(EGFP/cre)Cjt/J, Jackson stock number: 005622 
)91 mice for this analysis. 
See Appendix C for strain specific genotyping information (Page 94). See 
Appendix D for mouse strain information (Page 96). 
 
Whole Mount Immunostaining 
Wild type females crossed to either ShhEGFP/+ or Gli1LacZ/+ male mice were 
sacrificed when embryos were at the stage designated. Embryos were removed 
from the uterus; their chest cavities were opened, then fixed in 4% PFA for 30 
minutes at room temperature, and rinsed with PBS for 15 minutes. Thoracic aortas 
and carotid arties were then dissected out, as arterial tissues are less fragile when 
dissected after fixation.  
Antigen retrieval methods vary based on the primary antibody used. See 
appendix B for list of antibodies and dilutions and notes on antigen retrieval 
conditions. 
Samples were blocked at room temperature with 2% normal donkey serum 
(NDS) + 2% normal goat serum (NGS) + 0.1% bovine serum albumin (BSA) in PBS 
for one hour. Primary antibody was diluted in 2% normal donkey serum (NDS) + 2% 
NGS + 0.1% BSA in PBS and incubated overnight at 4⁰C. Samples were rinsed in 
PBS for 15 minutes, and blocked again at room temperature for 1 hour in recycled 
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blocking solution. Secondary antibody diluted in 0.1% BSA in PBS was applied to 
the tissue for 2 hours at room temperature. Samples were then rinsed in PBS for 15 
minutes. Hoechst dye (Molecular Probes) was diluted to 1μg/ml in H2O, and applied 
for 1 minute. Tissue samples were washed briefly in H2O, followed by a brief wash in 
PBS before storage in a 1:1 glycerol: PBS solution at 4⁰C. Samples can be stored at 
these conditions protected from light for several months to a year with little to no loss 
of signal. Samples were imaged on a Leica SP5 Confocal Laser Scanning 
Microscope.  
 
Xgal Staining 
Embryos were fixed using 0.2% gluteraldehyde solution in a 0.1M sodium 
phosphate buffer pH 7.3 containing 2mM MgCl2 and 5mM EGTA for 1 hour at room 
temperature. Samples were then washed three times for 30 minutes at room 
temperature with rinse buffer pH 7.3 containing 0.1M sodium phosphate, 2mM 
MgCl2, and 0.1% Triton X100. Finally, tissue samples were stained overnight in a 
shaking incubator at 50 rpm and 37°C using X-gal staining buffer pH7.3, composed 
of 5mM potassium ferricyanide, 5mM potassium ferrocyanide, 0.02M Tris-Cl, and 
1mg/ml Xgal (Bioline) or Rose-β-D-gal (Biotium Inc.) diluted in the rinse buffer 
described above. Tissue samples were post-fixed in 4% PFA for 30 minutes at room 
temperature and stored in PBS. 
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Sectioning 
Frozen sections were obtained by first fixing tissues in 4% PFA for 30 minutes 
at room temperature. Samples were then taken through a sucrose gradient in PBS 
at 4°C, with 10%, 15%, 20%, and 30% sucrose washes 2 hours each, followed by a 
2 hour 1:1 30% sucrose in PBS:OCT wash. Samples were then oriented and 
embedded in OCT and frozen on dry ice and stored and cut at -20°C. Blocks can be 
stored at -20°C for 2-3 weeks. After this time, the OCT begins to dry out and 
sections are more brittle and prone to shredding. If blocks are older than a few 
weeks, melt, and re-embed in fresh OCT. Sections were cut at 6μm on a Leica 
Cryostat model CM3050S.  
Paraffin sections were obtained by first fixing tissues in 4% PFA for 30 
minutes at room temperature. Samples were then dehydrated by taking tissues 
through an ethanol gradient, with two 15 minute washes each for 30% EtOH + 0.9% 
NaCl, 50% EtOH + 0.9% NaCl, 70% EtOH, 95% EtOH, 100% EtOH. Samples were 
cleared by washing twice each with 1:1 100% EtOH: Histoclear (National 
Diagnostics) and 100% Histoclear for 15 minutes each wash. Tissue samples were 
next washed in 1:1 Histoclear: paraffin wax at 60°C for an hour, and finally incubated 
in clean wax at 60°C overnight and oriented and embedded. Sections were cut at 
6μm.   
Sections were counterstained with Nuclear Fast Red (ENG Scientific Inc.) for 
approximately 1 minute. Excess stain was washed off briefly in water. Slides were 
allowed to air dry before coverslipping with Mowiol (Polysciences) dissolved in in 
glycerol, prepared according to the manufacturer’s instructions.  
61 
 
 
Results 
Gli1LacZ/+ Expression through Embryonic Development  
Starting at e11.5, we examined Gli1LacZ/+ expression every day through birth. 
Strikingly, we observe that there is a region of Gli1LacZ/+-positive cells that lies 
adjacent to the vessel on the dorsal side from e11.5 through e14.5. Between e13.5 
and e14.5, Gli1LacZ/+ positive cells begin to appear on the ventral side of the wall. 
This pattern of expression begins in the thoracic descending aorta, followed by the 
carotid arteries. The aortic arch is void of Gli1LacZ/+-positive cells until e16.5. The 
ductus arteriosus, and later the ligamentum arteriosum, never appears to fully be 
covered in Hh responsive cells (Supplemental Figure 3).  The coronary arteries 
begin expressing Gli1LacZ/+ between e16.5 and e17.5, and are fully covered by e18.5. 
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Figure 13: Hedgehog signaling in adventitial development. A time 
course of Gli1LacZ/+ expression was performed through arterial 
development from e11.5-birth. Gli1LacZ/+ expression does not appear on 
the ventral side of the aorta until e14.5 (P, black arrow). Gli1LacZ/+ 
expression does not extend up into the ventral aortic arch until e16.5 
(V, white arrow). Coronary arteries express Gli1LacZ/+ starting between 
e16.5 and e17.5 (U, Y, white double arrow). Panel Z for e17.5 was 
stained with Rose-β-D-gal instead of X-gal, showing a magenta 
pigment instead of blue where β-gal is active. 
 
 
Figure 14: Gli1LacZ/+ positive mesenchyme lies dorsal to the aorta in 
development. At embryonic day 13.5, ribs and the perichondrial 
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mesenchyme between them (arrow) express Gli1LacZ/+. It is possible 
that this mesenchyme participates in making adventitia.  
 
Shh Expression in Development 
Similar to results with Gli1LacZ/+, we observe that Shh expressing cells do not 
invest in the vasculature until around e14.5. At e12.5 and e13.5, nearly no ShhEGFP/+-
positive cells can be found in the aorta and carotids (Figure 15 A, B). By e14.5 
however, ShhEGFP/+-positive cells have invested into the outside of the wall of the 
descending thoracic aorta (Figure 15 D-F), but not the aortic arch (Figure 15C). At 
e15.5 and e16.5, the aortic arch becomes invested with Shh expressing cells (Figure 
15 G-I). This is consistent with data from Gli1LacZ/+ reporter mice (Figure 13). 
Further analysis is required to verify the cell types that are Gli1LacZ/+-positive 
and ShhEGFP/+ positive in embryonic development. CD68-positive macrophages 
express Shh-N protein at e14.5 in the thoracic descending aorta (Figure 15F, 
arrows). AdvSca1 cells do not appear to express Shh protein in mid-late gestation 
(e15.5, Figure 17), despite expressing ShhEGFP/+ in the perinatal time period. When 
AdvSca1 cells begin to express Shh is not yet known, but this analysis is in 
progress. It is possible that fibroblasts and/or other leukocytes are expressing Shh 
during development in addition to the CD68-positive macrophages. Adipocytes do 
not appear until late in gestation, so it is unlikely that these are a primary source of 
Shh in the development of the adventitia. 
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Figure 15: Shh expression in arterial development. Few Shh 
expressing cells are in the aorta at e12.5 and e13.5 (A, B). By e14.5, 
many Shh expressing cells have invested in the outer layers of the 
thoracic aorta wall (D, E, F), but not up in the aortic arch (C). The aortic 
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arch becomes invested in Shh-positive cells at e15.5 and e16.5 
(G,H,I), with a concentration of Shh-expressing cells in the aortic root 
at e15.5 (G)  and lesser-curvature of the aorta at e16.5 (I). See Figure 
17 for more images of Shh protein distribution at e15.5. 
 
 
AdvSca1 Cells in Development 
Passman et al. reported that AdvSca1 cells were not found until around e16.5 
25. This analysis was conducted using frozen tissue sections through the aortic root. 
Using whole mount confocal microscopy, we observe that AdvSca1 cells can be 
found in the anterior end of the descending thoracic aorta at least as early as e14.5 
in a cluster on the dorsal side (Figure 16). Whole mount confocal microscopy is a 
useful tool for studying the adventitia to better appreciate the three dimensional 
architecture of this complex layer of the artery wall. This is especially true in 
development, as the adventitia’s spatiotemporal development is not uniform across 
the whole vasculature. 
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Figure 16: AdvSca1 in development: e14.5. AdvSca1 progenitors are 
located in a large cluster on the dorsal side of the thoracic aorta, with 
few detected cells on the ventral side, and some smaller clusters on 
the dorsal aortic arch.  
 
 
68 
 
At e15.5, we detect AdvSca1 cells distributed in a similar pattern to e14.5. We 
observe that they cluster together along the dorsal side of the thoracic aorta. These 
AdvSca1 cells are found within a region expressing Shh-N, although themselves are 
not Shh-N-positive at this time (Figure 17D). There are no AdvSca1 cells detected in 
the carotid arteries, aortic arch, or abdominal aorta at e15.5 (Figure 17).  
At e16.5, AdvSca1 cells exist in scattered patches in the vasculature, with 
most being proximal to the heart, and enrichment for patches on the dorsal side of 
the vessels (Figure 18). There are many more clusters of cells at e16.5 than 
previously. No AdvSca1 cells were found posterior to the thoracic aorta. Unlike at 
e15.5, there are AdvSca1 cells located in the carotids, aortic arch, and several cells 
can be detected on the ventral side of the vasculature.  
We also note that patches of AdvSca1 cells tend to be found in regions of 
branch points, although not in every occasion. One potential explanation for this is 
that regions of disturbed flow, such as branch points or the lesser curvature of the 
aorta, tend to be more hypoxic223. It has been shown that stem cells are sensitive to 
oxygen tension, and many niches tend to be more hypoxic211-213. AdvSca1 cells may 
also be sensitive to oxygen levels, and colonize more hypoxic regions preferentially. 
Further study will be required to test AdvSca1 cells sensitivity to oxygen.  
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Figure 17: AdvSca1 cells in development: e15.5. AdvSca1 cells are 
found in a cluster on the dorsal side of the thoracic aorta at e15.5 in a 
region expressing Shh-N. Not all regions that express Shh-N have 
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AdvSca1 cells, as there are abundant Shh-N-positive cells in the 
ascending aorta. Arrowhead: region focused in panel D; Arrow: region 
focused in panel C. 
 
 
Figure 18: AdvSca1 cells in development: e16.5. Sca1-positive 
progenitors reside in the vasculature at e16.5, but are unevenly 
distributed. More AdvSca1 cells reside on the dorsal side of the aortic 
arch and carotids. Few AdvSca1 cells can be found on the ventral side 
of the thoracic aorta, and no detectable AdvSca1 cells reside in the 
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abdominal aorta at this time. Dashed square in A is shown in D. 
Dashed square in C is shown in E. Dashed line in E shows division 
between the thoracic and abdominal aorta. 
 
Discussion 
Vascular Wall Development 
The molecular and genetic pathways that govern early vasculogenesis, 
arterial-venous specification, and vascular patterning have been well studied147, 217, 
221, 224. Mechanisms that control the later stages of vascular development, and 
especially adventitial development, are still unclear. Understanding the cessation of 
the smooth muscle media formation program will be informative to the initiation of 
adventitia formation, as these two events occur at approximately the same time: 
around e14.5-e15.5 in the mouse225. 
Work by Wolinsky and Glagov showed that the number of layers of smooth 
muscle in the media of mature arteries is characteristic of species and vessel type, 
correlating to the normalization of circumferential wall stress226. As an example, the 
aorta of a mouse has 6-8 layers of smooth muscle and elastin, the rat has 8-10 
layers, and human aortas have 40-50 layers20. This number of layers is not entirely 
contingent on body size, and does not change to accommodate changes in mass. 
This is best shown in a mouse model of gigantism where rat growth hormone under 
the metallothionein promoter (MtGH) was injected into the pronuclei of fertilized 
mouse eggs. These mice have an increase in body mass 1.8 fold over its wild type 
littermates, with proportional increases in the mass of internal organs227. To 
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accommodate increase in demand for blood flow, the aorta exhibited several 
structural changes from wild type including a 1.22 fold increase in lumen diameter, a 
1.24 fold increase in wall thickness, and 30% more SMCs228. Despite the increase in 
the number of SMCs and the thickness of the wall, the number of layers of smooth 
muscle is unchanged in these mice221, 228.  
Insight into the mechanism to control the number of layers comes from mice 
hypomorphic for elastin. Knockout of elastin (Eln-/-) is perinatal lethal, with the mice 
developing supravalvular aortic stenosis from over-proliferation and disorganization 
of SMCs to the point that they occlude the aorta225. Mice that are hemizygous for 
elastin (Eln+/-) are viable, and have a 35% increase in the number of layers in the 
tunica media229. The extra layers begin to appear at approximately embryonic day 
18.5 (E18.5) and are completed by birth230, 231. These ectopic layers are added from 
the adventitial side of the wall, preserving lumen diameter. Because these ectopic 
layers are added to the adventitial side of the media, it has been proposed that the 
ectopic SMCs come from differentiating AdvSca1 cells184.  
Eln+/- mice may represent a small window of time between e18.5 and birth 
that the artery wall has the potential to adjust the number of smooth muscle layers to 
normalize wall strain221. It is possible that this potential may still be retained by adult 
vessels to respond to injury, or is pathologically reactivated in situations like 
pulmonary hypertension20, 184. In pulmonary hypertension, hypoxia induces dramatic 
remodeling of the pulmonary artery. Pulmonary arteries of chronically (2 wk) hypoxic 
neonatal calves demonstrate marked adventitial thickening, excessive deposition of 
extracellular matrix proteins such as type I collagen, fibronectin, and tenascin-C, 
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augmented cell proliferation, myofibroblast accumulation/differentiation, cytokine 
production such as the active isoform of TGF-β1, and recruitment of circulating 
leukocytes and fibrocytes184. Further study is necessary to pinpoint the factors 
responsible for maintaining or reactivating plasticity of the artery wall to respond in 
this fashion. Identification of these pathways will be useful therapeutic targets to 
inhibit in obstructive arterial disease, or reactivate in medial dissection. These 
pathways will also likely be informative of the regulative mechanisms controlling the 
proliferation and differentiation of AdvSca1 cells. 
 
Lineage of AdvSca1 Cells 
The developmental origin and lineage of the adventitia, and specifically 
AdvSca1 cells, is still unclear. Circulating bone marrow derived progenitor cells have 
been suggested to contribute to neointimal lesion formation. While recent work 
debates whether this is accurate232, 233, bone marrow is a potential source of 
AdvSca1 cells. Hu et al. examined this possibility by reconstituting bone marrow 
from lethally irradiated wild type mice with genetically labeled Rosa26LacZ/+ marrow. 
Six months after bone marrow reconstitution, they examined the cells in the 
adventitia, and did not find any β-gal positive AdvSca1 cells. Further work from our 
lab showed that AdvSca1 cells were not labeled by Tie2cre/+ mice40. Tie2 labels cells 
of hematopoietic or endothelial origin234.  
Work from our lab further investigated potential lineages for AdvSca1 cells40. 
There are several known origins of vascular smooth muscle cells235. Using these 
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known lineages, our lab used lineage tracing cre mice to determine if AdvSca1 cells 
were also derived from one or more of these lineages. 
Cardiac neural crest cells contribute to the aortic arch and common carotid 
artery smooth muscle, as well as the neurons of cardiac innervation224, 235. They also 
mediate the complex remodeling of the symmetrical pharyngeal arch arteries into the 
aortic arch, carotid, and subclavian arteries, as well as septation of the outflow tract 
into pulmonary and systemic circulation224. Additionally, neural crest derived 
melanocytes (chromatophores) can be found in the frog adventitia (Supplemental 
figure 4), unlike in mammals. It has been shown that Indian Hedgehog is required for 
proper migration of Xenopus neural crest cells236. Neural crest derived cells can be 
labeled and traced in the mouse using Wnt1cre crossed to R26R. Cross sectional 
analysis of these mice reveals that the adventitia and AdvSca1 cells do not derive 
from neural crest.  
Somite derived paraxial mesoderm contributes to the smooth muscle of the 
thoracic aorta. Paraxial mesoderm contributes to several lineages sclerotome 
(cartilage), myotome (skeletal muscle), syndotome (tendon), dermatome (dermis), 
and endothelial cells237. Work from our lab tested Nkx3.2cre/+ to label somite derived 
cells, and did not detect any in the adventitia40. Other somite derived paraxial 
mesoderm cre mouse lines include Tbx6cre/+ 238 and Meox1cre/+ 239. These could be 
informative of adventitial origins.  
Wilm’s Tumor 1 cre (WT1cre/+), which is a marker of cells derived from the 
mesothelium was also tested, and the adventitia was not labeled. 
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Other possibilities for lineages for AdvSca1 cells are anterior heart field, 
splanchnic mesoderm, mesoangioblasts, yolk sac, and foregut. Anterior heart field 
(mef2ccre/+), splanchnic mesoderm, and mesoangioblasts have all been shown to 
contribute to vascular smooth muscle diversity235, and splanchnic mesoderm in 
particular also contributes to the myocardium and endocardium of the heart237, 240. 
Yolk sac derived macrophages are involved in angiogenesis in the brain during 
embryogenesis170, and contribute to hematopoiesis241. It is possible that the yolk sac 
may provide other cells as well. A recent study by Samokhvalov and colleagues 
using lineage tracing of Runx1-positive cells (yolk sac derived) found labeled cells 
that surrounded the dorsal aorta at e11.5 241. The study did not go later in 
development than e11.5, but these cells could possibly contribute to adventitia. 
Foregut contributes to lung and esophagus: both Hh responsive structures in close 
contact to the dorsal aortic arch.  Further studies will be required to determine the 
developmental origin of the AdvSca1 cells.  
 
Next Steps 
We observe that Gli1LacZ/+ begins to be expressed on the outer ventral part of 
the aorta wall between e13.5 and e14.5. We hypothesize that the Hh responsive 
cells on the dorsal side of the aorta migrate around ventrally at this time. The 
alternative explanation is that mesenchymal cells already in the ventral part of the 
wall activate Gli1 de-novo during this time window. 
To address this, we will use Gli1creERT2/+, a tamoxifen inducible cre 
recombinase192. Using Rosa 26 cre reporter strains (R26R), that include a reporter 
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gene like LacZ behind a stop codon flanked by two LoxP sites, we can irreversibly 
activate the reporter in Gli1 expressing cells at a specific time in development, and 
observe where those cells and their progeny end up later in development. We will 
treat pregnant R26R females crossed to male Gli1creERT2/+ mice with tamoxifen by 
oral gavage at time points between e10.5 and e13.5 to label the mesenchyme dorsal 
to the aorta. Then we will examine newborn pups for expression of the reporter.  
It will also be informative to do lineage tracing of Shh producing cells with 
ShhcreERT2/+, another tamoxifen inducible cre recombinase91 as some of the cell types 
that are positive for Gli1LacZ/+ also appear to be positive for ShhEGFP/+. We will treat 
pregnant R26R females crossed to male ShhcreERT2/+ mice with tamoxifen by oral 
gavage or IP injection at time points between e10.5 and e13.5 to label Shh 
expressing cells. Then we will examine newborn pups for expression of the reporter. 
These results will be compared to Gli1creERT2/+/R26RLacZ/+ labeled with tamoxifen at 
the same time points. 
An alternative approach to determining if Hh responsive cells migrate around 
ventrally from the dorsal side of the aorta would be to use transgenic zebrafish for 
ShhGFP/+ and Gli1GFP/+ and time lapse microscopy242, 243. This way we can view 
movements of Gli1GFP/+-positive or ShhGFP/+-positive cells as they happen. Time-
lapse microscopy with live zebrafish embryos is a common technique and a useful 
attribute of zebrafish as a model system244.  
The zebrafish circulatory system has been well studied, and many transgenic 
models are available to visualize blood vessels in live embryos, such as the Fli1GFP/+ 
and Flk1mCherry/+ fish that labels endothelial cells245. Vasculogenesis begins early in 
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the zebrafish, with angioblasts beginning to form around 14 hours post fertilization. 
At 17 hours, the angioblasts are already expressing markers of arterial/venous 
specification. The longitudinally aligned major axial vessels of the trunk, the dorsal 
aorta, and posterior cardinal vein, become patent and blood conducting about 30 
hours post fertilization. The axial vessels are linked by dorsoventrally aligned 
intersegmental arteries and intersegmental veins, nearly all of which are perfused by 
3 days post fertilization245. Zebrafish embryos lacking Hh signaling display defects of 
the primary intersegmental vessel sprouting242. Shh appears to promote the 
maturation of blood vessels by regulating the levels of angiopoietin-1 and -2 and 
VEGF242. It is in this second day post fertilization between the formation of the major 
axial vessels and perfusion of the intersegmental arteries around day 3 as the dorsal 
aorta is maturing that we would monitor with time lapse imaging for ShhGFP/+ and 
Gli1GFP/+ expression.  
An obvious first step to this experiment however, is to determine if zebrafish 
express markers of Hh signaling in the adventitia of the dorsal aorta. Zebrafish have 
2 homologs of the Shh gene, Sonic Hedgehog (Shh A) and Tiggy-Winkle Hedgehog 
(twhh) (now named Shh B)246. Zebrafish also express 2 different Indian Hedgehog 
genes (Ihha and Ihhb), as well as Desert Hedgehog247. An analysis of all 5 Hh genes 
and the other Hh pathway elements (Ptc, Smo, Gli1-3) will be important to verify 
before proceeding with time lapse video capture.  
 
 
  
 
 
 
CHAPTER 4 
SUMMARY AND FUTURE DIRECTIONS 
 
Summary of Results 
1. The adventitia is a remarkably dynamic and diverse niche community of 
cell types that interact through a number of different signaling pathways, 
with one major player being Shh.  
2. We have identified that CD68-positive tissue resident macrophages, 
Perilipin A-positive adipocytes, and Sca1-positive adventitial progenitor 
cells all participate in making and responding to Shh signal, as shown 
using transgenic reporter mice.  
3. Hedgehog responsive cells appear on the ventral side of the developing 
artery wall between e13.5 and e14.5 in the mouse, and are present on the 
dorsal side at least as early as e11.5, although these cells may be a part 
of the perichondrium, and are not integrated into the wall. 
4. AdvSca1 cells are present in the adventitia at least as early as e14.5, and 
are found in clusters that are enriched on the dorsal side of the aorta.  
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5. There is a rapidly growing microvascular network in the adventitia and 
periadventitial adipose tissue that closely associates with Hh responsive 
cells, and resides in a Shh rich matrix. 
 
Figure 19: Model of the adventitial niche. Adventitial Sca1 positive 
progenitor cells are a heterogeneous population (Green cells with 
different tinted centers) with the ability to differentiate into many 
different cell types (dashed arrows). Some are poised to become 
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smooth muscle cells (red) to repair and replace aging SMCs in the 
tunica media (SMC, green cells with red tinted center). Others are 
poised to become pericytes (dark purple) that support the vasa 
vasorum (P, green cells with purple tinted center). Some are poised to 
become monocyte/macrophages (MΦ, green cells with turquoise tinted 
center)27. Still others are poised to become adipocytes (Ad, green cell 
with yellow tinted center). Additionally, the adventitia provides growth 
factors (Solid arrows, blue, red, purple, brown spheres) and ECM 
components (grey and brown lines) from fibroblasts (F, light purple 
cells) tissue resident macrophages (MΦ, blue cells) and adipocytes 
(Ad, light yellow cells) that build and maintain the AdvSca1 niche. In 
addition to AdvSca1 cells, the adventitia supports a small population of 
hematopoietic stem cells (HSC, yellow-green cells)26-28. Another 
important feature and function of the adventitia is the vasa vasorum 
(orange) that provides oxygen and nutrients to the outer layers of the 
tunica media that cannot receive it by diffusion from the lumen of the 
vessel.  
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Figure 20: Model of Gli1LacZ/+ expression in arterial development. We 
hypothesize that Gli1LacZ/+ expression patterns reflect the development 
of the adventitia. Hh responsive “pre-adventitia” from the mesenchyme 
adjacent to the dorsal side of the developing vasculature begins to 
migrate ventrally sometime between e13.5 and e14.5 to cover the 
entire vasculature by birth, with the exception of the ductus 
arteriosus/ligamentum arteriosum. 
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Future Directions 
Determine the Heterogeneity of the Advsca1 Population and Classify 
Subpopulations 
It is likely that the marker Sca1 labels a heterogeneous population of cells. In 
vitro studies of isolated AdvSca1 cells show that roughly ¼ of the cells retain their 
Sca1 phenotype, ½ differentiate into SMCs, and the remaining ¼ lose Sca1 
expression but do not detectably express smooth muscle markers in serum 
containing medium without supplement of additional growth factors20, 25, 40. Growth 
factor stimulation of AdvSca1 isolated cells only produced a small percentage of 
osteogenic or adipogenic cells20, 25. Psaltis et al. found that aortic adventitial cells 
generated a broad spectrum of multipotent and lineage-specific hematopoietic 
colony-forming units, with a preponderance of macrophage colony-forming units27. 
We hypothesize that Sca1 represents a heterogeneous population of progenitors 
with limited potentials and not a homogeneous population of multipotent cells. 
To test this hypothesis, we would use single-cell fluorescence activated cell 
sorting (FACS) to grow up clones of single AdvSca1 cells. Once sufficient quantities 
of clones have been grown up, we will test the potential of each clone to produce the 
lineages we know the AdvSca1 population as a whole is capable of becoming by 
treatment of cells from each clone with growth factors: PDGF-BB for SMCs23, insulin 
+ dexamethasone + isobutylmethylxanthine for adipocytes248, BMP-2 + heparin 
sulfate for osteocytes249, VEGF + bFGF + endothelial cell growth supplement for 
endothelial cells250, and CSF-1 for macrophages251.  Multipotent cells should be able 
to respond to each treatment and become each cell type tested. Data from 
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Campagnolo et al. show that AdvSca1 cells from the human saphenous vein can be 
cloned with a success rate of about ~2% of plated cells proliferating sufficiently to 
make clones. They find that clones are plastic and can differentiate into various 
mesenchymal cell types, and additionally β-tubulin III-positive nerves39.  
Culture conditions will be important to test in this analysis. Howson et al. 
found that AdvSca1 cells can form suspended spheroids in serum-free medium 
supplemented with bFGF, but when serum is added cells stick down to the culture 
dish and differentiate into SMCs41. Passman et al. confirmed that about half of 
AdvSca1 cells cultured in serum become SMCs, but ¼ of the cells retain Sca125. It 
will be important to ensure that this subpopulation of cells are not selected for when 
growing clones as they will not be representative of the whole population of AdvSca1 
cells. 
Additionally, these experiments will be repeated under hypoxic conditions to 
see if hypoxia shifts the potential of individual AdvSca1 cells. It has been shown that 
Sca1-positive cells become more adipogenic when pre-exposed to hypoxic 
conditions (2% oxygen) before switching to normoxic conditions (21% oxygen)213. 
Hypoxia also enhanced the ability of Sca1-positive adipose tissue derived 
mesenchymal stem cells to proliferate in culture213. 
Clones will also be tested for gene expression profile differences. If a 
particular clone is predisposed to make a specific cell type, we hypothesize that it 
would also have differences in gene expression and epigenetic marks that other 
clones will not. Microarray analysis will be useful for this study to analyze gene 
expression as well as to find markers that are specific for sub-populations of 
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AdvSca1 cells. Additional cell-type specific cell-surface antigens are needed to verify 
purity of AdvSca1 isolations, select a specific population for study, better understand 
niche interactions, and profile the relative ratios of each subpopulation. Ratios of 
subpopulations may be different in disease situations, and may serve as useful 
biomarkers for disease risk or indicators of disease severity.  Psaltis et al. found that 
in lesion free APOE-knockout mice, there were a greater percentage of macrophage 
colony forming AdvSca1 cells than wild type mice27.  
Alternatively, if AdvSca1 cells are not amenable to growing in culture, we can 
sort single cells into 96 well plates, and test each plate for the percentage of single 
cells that can differentiate into the cell type of choice when subjected to growth 
medium. While this method is not ideal, the proliferative capacity of AdvSca1 cells 
may be limiting to clonal analysis. 
As an alternative approach to studying gene expression in AdvSca1 cells if 
clonal analysis does not work to isolate sufficient quantities of RNA by standard 
methods, we would use single cell RNA isolation and gene expression analysis on a 
cell by cell basis. This technique is being optimized by several groups192, 193, and kits 
are becoming available from a few companies to perform this technique at the bench 
(Life Technologies, Signosis).  
 
Determine a Role for Shh Signaling in Macrophages in the Development of the 
Vasa Vasorum 
The vasa vasorum is an important part of maintaining the adventitial niche. 
Removal of the adventitia from rabbit carotid arteries results in formation of a 
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hyperplastic intimal lesion79. Similarly, removal of rat abdominal aortic adventitia 
shows an initial severe trauma of the endothelium and intimal hyperplasia as early 
as one month after injury80. The researchers in both of these studies suggested that 
this response was due to the removal of adventitial microvessels and the ensuing 
hypoxia in the artery wall. Hypoxia has been shown to enhance adipogenesis in 
Sca1 cells213, implicating the vasa vasorum as an important component of the 
adventitial niche. 
CD68-positive macrophages are very strongly positive for all of our hedgehog 
reporter mice, including ShhEGFP/+, Ptc1LacZ/+, and Gli1LacZ/+, indicating that they both 
make and respond to Shh. These cells closely associate with microvessels, and 
other recent studies have shown that macrophages play a key role in anastomosis of 
tip cells in angiogenic vessel plexuses170. We hypothesize that Shh signaling, 
particularly in these resident macrophages, induces the release of growth and 
angiogenic factors that promote increases in mass of the adventitia and formation of 
vasa vasorum microvessels in the perinatal period in vivo.  
To test this hypothesis, we would first disrupt Shh signaling and monitor 
effects on overall growth of the adventitia in the perinatal period, and on 
development of the vasa vasorum within this layer of artery wall. Shh signaling 
would be disrupted using two approaches in vivo. First, we would genetically disrupt 
signaling using the cre-lox system to target hedgehog signal transduction in 
macrophages specifically. Mice deficient in the Shh signaling receptor smoothened 
(Smo) are unable to respond to any of the vertebrate Hh ligands. We would use 
Smoflox/flox mice252 crossed with macrophage-specific cre mice (LysMcre/cre)253 to 
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inhibit macrophages from being able to respond to Hh signal. As an alternative 
approach, we would disrupt smoothened signaling pharmacologically with the well-
studied inhibitor of smoothened signaling, cyclopamine and determine effects on 
perinatal growth of the adventitia and formation of adventitial microvessels of the 
vasa vasorum. 
Conversely, we would look at how constitutive activation of smoothened in 
these cells affects the growth of the adventitia. We hypothesize that activity of Shh 
drops to a minimal baseline level of activity after the perinatal period of about 10-14 
days after birth, based on data from PtcLacZ/+ mice. Using the mouse line that puts an 
activated form of smoothened behind a floxed stop codon under the control of the 
ubiquitous Rosa26 promoter254, we can constitutively activate smoothened in 
macrophages when we cross them to the LysMcre/cre mice. Additionally, we can apply 
recombinant Shh protein to the adventitia in adult mice, as an alternative approach, 
although this is less specific to macrophages.  
 
Preliminary data 
Initial characterization of the LysMcre/+/R26RYFP/+ mice reveal no 
recombination in AdvSca1 cells, adipocytes, or medial SMCs (Figure 21 D, E, F). 
Minimal recombination occurs in activated macrophages that are Mac2-positive, but 
this population contributes to a minimal percentage of overall adventitial cells (Figure 
21 C). We also observe about 70% recombination in CD68-positive adventitial 
resident macrophages (Figure 21 A,B). This mouse line will serve as a very useful 
tool for studying this population of cells.  
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Figure 21: Characterization of LysMcre/+/R26RYFP/+ mice. Cre 
expression and recombination occurs in about 70% of CD68-positive 
macrophages (A, B), and a few Mac2-positive activated macrophages 
(C). No recombination is detected in AdvSca1 cells, adipocytes, or 
smooth muscle (D, E, F). 
 
In a first round of breeding of LysMcre/+/Smoflox/flox mice, we observe that these 
mice are viable, and are born at expected Mendelian ratios. There are no obvious 
gross morphological differences between wild type and mutant mice. It is possible 
that the differential phenotype of these mice will only be seen when aggravated with 
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an injury or disease stimulus. It is also possible that the wild type macrophages that 
escape recombination are able to compensate for the lack of normal hedgehog 
signaling response of the mutant cells. Further characterization is required to 
determine the effect of this mutation.  
A recent study by Schumacher and colleagues made LysMcre/+/Smoflox/flox 
mice to examine inflammation in response to gastric bacterial infection176. While they 
were not interested in angiogenesis in these mice, they reported that macrophages 
use Shh secreted by the stomach as a chemoattractant to respond to infection. 
LysMcre/+/Smoflox/flox mice had reduced levels of inflammation in response to infection 
by H pylori bacteria176. These data suggest that response to infection and injury in 
these mice will be impaired. It is possible that inflammation in response to vascular 
injury such as a hindlimb ischemia model, balloon injury, or carotid ligation would be 
reduced in LysMcre/+/Smoflox/flox compared to controls.  
Data from Fantin et al. hint at possible mechanisms for why the phenotypes of 
this mouse model are so subtle. In studying the role of macrophages on 
angiogenesis in the brain, they crossed LysMcre/cre mice to R26R-diptheria toxin 
mice, thus specifically killing LysM-positive cells. They found that angiogenesis in 
the brain was unaffected, reporting that LysM-negative macrophages derived from 
the yolk sac were responsible for brain angiogenesis170. The authors pointed to a 
study that used macrophage deficient mice in studying footplate remodeling, as it 
has been shown that macrophages clear the synchronized apoptotic cells between 
digits255. Neighboring mesenchymal cells were able to clear the debris of the 
apoptotic cells in the absence of tissue macrophages, albeit less efficiently255. Fantin 
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et al. speculate that the angiogenic effects of macrophages might be compensated 
for by other cell types in mice that lack macrophages170.   
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APPENDICES 
Appendix A: Supplemental Figures 
 
 
Supplemental Figure 1: AdvSca1 cell differentiation potential in vivo. 
AdvSca1 cells isolated from Rosa26 mice with membrane localized 
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tdTomato (mTmG, see appendix D for mouse strain information) were 
incubated in Matrigel plugs treated with 0.5 µg/mL human FGF2 and 
60 U/mL heparin for 10 days injected into wild type mice. Single 
confocal Z-sections indicate tdTomato co-localization with endothelial 
cell marker PECAM (arrowheads, A), Perilipin A, a marker of 
adipocytes (B), and macrophage marker CD68 (C).   Images courtesy 
of Dr. Jenna Regan 40.  
 
 
Supplemental Figure 2: Schematic of early arteriogenesis. Smooth 
muscle progenitors are recruited to the endothelial vascular plexus. 
They begin to differentiate and invest in the wall, and then through 
Notch signaling, and processes still unclear, the wall undergoes 
maturation into a multilayered structure complete with adventitia.256 
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Supplemental Figure 3: The ductus arteriosus and ligamentum 
arteriosum are largely void of Gli1LacZ/+-positive cells throughout 
development. 
 
 
Supplemental Figure 4: Neural crest derived melanocytes closely 
associate with the vasculature of the African clawed frog (Xenopus 
laevis). Image of unstained adult male frog small intestine vasculature. 
Frog tissue courtesy of Dr. Frank Conlon. 
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Supplemental Figure 5: Gli1LacZ/+ expression in smaller caliber vessels. 
Gli1LacZ/+ is expressed in the brain, the mesentery, the uterine arteries, 
the femoral arteries, and fine caliber coronary arteries during neonatal 
development. Coronaries were measured with Leica LAS software 
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using the “distance line” analysis tool. All samples are newborn mice 
P0-P6. 
 
 
Supplemental Figure 6: Flow analysis of adventitial cells for AdvSca1.  
A) The adult mouse adventitia contains abundant AdvSca1 cells. B) 
Total adventitial cells from 3 wild type adult (6-8mo) C57Bl/6 mouse 
thoracic aortas, unstained control, gated with a false positive rate of 
1.56% of cells. C) Total adventitial cells from 3 wild type adult (6-8mo) 
C57Bl/6 mouse thoracic aortas were stained with anti-Sca1-FITC 
antibody. Using the same gate as A, 59.1% of the cells in the 
population stained positive for Sca1-FITC.  
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Appendix B: List of Antibodies and Reagents 
Antibody Host Source Cat # Dilution Staining Notes 
Acetylated α 
tubulin 
Mouse 
IgG2b 
Sigma M7451 1:1000 Triton 
BOC Mouse 
IgG2a 
R&D MAB20361 1:100 No antigen retrieval 
CD68 Rat IgG2a AbD Serotec MCA1957 1:200 No antigen retrieval, but 
can use methanol 
Chicken IgY-
Alexa 488 
Goat Molecular 
Probes 
A11039 1:500 Secondary antibody 
Chicken IgY-
Alexa 594 
Goat Molecular 
Probes 
A11042 1:500 Secondary antibody 
GFP Rabbit Invitrogen A11122 1:200 Methanol  
GFP Chicken Abcam Ab13970 1:1000 Methanol  
Ki67 Mouse 
IgG1 
Pharmingen 550609 1:200 Methanol  
KLF4 Rabbit Santa Cruz sc20691 1:100 Triton 
Mouse IgG1-
Alexa 594 
Goat Molecular 
Probes 
A21125 1:500 Secondary antibody 
Mouse IgG2a-
Alexa 488 
Goat Molecular 
Probes 
A21131 1:500 Secondary antibody 
Mouse IgG2a-
Alexa 594 
Goat Molecular 
Probes 
A21135 1:500 Secondary antibody 
Mouse IgG2a-
Alexa 633 
Goat Molecular 
Probes 
A21136 1:500 Secondary antibody 
Mouse IgG2b- 
Alexa 594 
Goat Molecular 
Probes 
A21145 1:500 Secondary antibody 
Mouse IgG2b-
Alexa 488 
Goat Molecular 
Probes 
A21141 1:500 Secondary antibody 
Pecam Rat IgG2a Pharmingen 550274 1:200 No antigen retrieval 
needed, can use methanol 
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Perilipin A Rabbit IgG Sigma P1998 1:200 No antigen retrieval. 
Incompatible with Triton 
Phospho-
Histone H3 
Rabbit  Upstate  06-570 1:100 Best with Triton, also works 
with methanol 
Rabbit IgG-
Alexa 488 
Goat Molecular 
Probes 
A11008 1:500 Secondary antibody 
Rabbit IgG-
Alexa 594 
Goat Molecular 
Probes 
A11037 1:500 Secondary antibody 
Rat IgG- Alexa 
488 
Donkey Molecular 
Probes 
A11034 1:500 Secondary antibody 
Rat IgG- Alexa 
594 
Donkey Molecular 
Probes 
A21209 1:500 Secondary antibody 
Rat IgG- Alexa 
633 
Goat Molecular 
Probes 
A21094 1:500 Secondary antibody 
Sca1 Rat IgG2a Pharmingen 
(BD) 
553333 1:200 No antigen retrieval. 
Incompatible with Triton 
Sca1-FITC Rat IgG2a Miltenyi 130-092-
529 
1:20 No antigen retrieval. 
Incompatible with Triton 
Shh-C Goat R&D AF445 1:100 Best with no antigen 
retrieval or methanol 
Shh-N (5E1) Mouse 
IgG1 
DSHB 5E1 1:50 Incompatible with Triton 
SM-MHC Rabbit IgG Biomedical 
Technologies 
BT-562 1:100 Methanol or Triton 
SMαA Mouse 
IgG2a 
Sigma A2547 1:500 Methanol or Triton 
β-gal Mouse 
IgG2b 
Roche 1083104 1:200 Methanol or Triton 
β-tubulin III Mouse 
IgG2a 
Covance MMS-435P 1:1000 Triton 
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Reagent Source Cat# Dilution/Notes 
Click-It® EdU- 
Alexa 647 
Invitrogen C10340 Use manufacturer’s instructions for 
staining. 50mg/kg injected/mouse 
FITC-Dextran Sigma FD2000S High molecular weight (2000kDa) 
Heparin Sigma H3393 60 U/ml 
Histoclear National 
Diagnostics 
HS-200 - 
Hoechst Dye Molecular Probes 33258 1μg/ml in H2O 
Matrigel  BD Biosciences 356231 Growth factor reduced 
Mowiol Polysciences 17951-500 Use manufacturer’s instructions 
Nuclear fast red ENG Scientific Inc. 9040 Counterstain sections for ~ 1 minute, 
wash off excess with H2O 
OCT Tissue-tek 4583 - 
Recombinant 
human FGF basic 
Peprotech 100-18B 0.5μg/ml 
Rose-β-D-gal Biotium Inc. 10013 1 mg/ml working concentration 
Sca1 isolation kit Miltenyi Biotec 130-092-529 Sort over 2 columns, follow 
manufacturer’s instructions 
X-gal Bioline BIO 37035 1 mg/ml working concentration 
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Appendix C: Genotyping Primers 
Strain Forward Primer Reverse Primer 
Product 
Length 
Gli1LacZ GGGATCTGTGCCTGAAACTG AGGCGATTAAGTTGGGTAAC 286bp 
Gli1 WT GGGATCTGTGCCTGAAACTG AGGTGAGACGACTGCCAAGT 261bp 
Gli2LacZ CCTGGGGTCAGAAGACTGAG AGGCGATTAAGTTGGGTAAC 350bp 
Gli2 WT CCTGGGGTCAGAAGACTGAG CTGCTGTCCTCCAAGAGACC 230bp 
Ptc1LacZ 
(not gene 
specific) 
TTGGAGTGACGGCAGTTATCT
GGA 
TCAACCACCGCACGATAGAGAT
TC 
348bp 
Ptc1 WT CTGCGGCAAGTTTTTGGTTG AGGGCTTCTCGTTGGCTACAAG 200bp 
Ptc2LacZ 
GGGTGGGATTAGTATAATGCC
TGCTCT 
TCAAACATCTGGAGGGACTGTG
TAG 
476bp 
Ptc2 WT 
CCTAGAAATCCCTGTCTGAGA
TCTC 
TCAAACATCTGGAGGGACTGTG
TAG 
222bp 
ShhEGFP GGGACAGCTCACAAGTCCTC GGTGCGCTCCTGGACGTA 333bp 
Shh WT GGGACAGCTCACAAGTCCTG CTCGGCTACGTTGGGAATAA 200bp 
LysMcre CTTGGGCTGCCAGAATTTCTC CCCAGAAATGCCAGATTACG 701bp 
LysM WT CTTGGGCTGCCAGAATTTCTC TTACAGTCGGCCAGGCTGAC 346bp 
Smo flox 
CCACTGCGAGCCTTTGCGCT
AC 
GGCGCTACCGGTGGATGTGG 400bp 
Smo WT 
CCACTGCGAGCCTTTGCGCT
AC 
CCCATCACCTCCGCGTCGCA 170bp 
R26R YFP AAAGTCGCTCTGAGTTGTTAT AAGACCGCGAAGAGTTTGTC 320bp 
R26 WT AAAGTCGCTCTGAGTTGTTAT GGAGCGGGAGAAATGGATATG 600bp 
 
100 
 
Appendix D: Mouse Strain Information 
Gli1LacZ/+ mice were made by Alexandra Joyner. (Gli1tm2Alj/J, Jackson stock 
number: 008211)188. To make the Gli1LacZ/+ mice, a targeting vector was designed to 
insert a nuclear localized β-galactosidase (LacZ) cDNA and loxP-flanked, reverse-
oriented neo cassette into the first coding exon (exon 2) and delete the coding 
sequences in exons two to seven of the targeted gene. This construct was 
electroporated into 129S6/SvEvTac-derived W4 embryonic stem (ES) cells. 
Correctly targeted ES cells were injected into recipient blastocysts and chimeric 
mice were bred with 129SvEv (Taconic) mice. Next, mutant mice were bred to TK-
Cre transgenic mice (129SvEv genetic background) to remove the floxed neo 
cassette. The resulting Gli1LacZ/+ offspring were selectively bred to remove the TK-
Cre transgene and then subsequently maintained by breeding to Swiss Webster 
mice and also interbreeding for many generations prior to arrival at The Jackson 
Laboratory.188  
Gli2LacZ/+ mice were made by Alexandra Joyner (Gli2tm2.1Alj/J, Jackson stock 
number: 007922)189. To make the Gli2LacZ/+ mice, a targeting vector was designed 
with a nuclear localized β-galactosidase cDNA (with 1.7 kb of 3' UTR and three 
tandem SV40 poly A sequence repeats downstream) and followed by a reverse-
oriented loxP-flanked neo cassette. This construct was used to replace a portion of 
the first coding exon (exon 2) of the targeted gene (including the ATG start codon) 
via electroporation into 129S6/SvEvTac-derived W4 embryonic stem (ES) cells. 
Correctly targeted ES cells were injected into recipient blastocysts and chimeric 
mice were bred with Black Swiss Webster outbred mice. The resulting Gli2nlzki 
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heterozygotes were then bred to cre expressing mice (on a Swiss Webster genetic 
background) to remove the neo cassette, generating Gli2LacZ/+ offspring (with a 
single loxP site remaining after the SV40 polyA). These Gli2LacZ/+ mutant mice were 
bred to Swiss Webster mice for many generations prior to arrival at The Jackson 
Laboratory, and are maintained by crossing heterozygotes to wild type littermates.189 
Ptc1LacZ/+ mice were made by Matthew Scott (Ptch1tm1Mps/J, Jackson stock 
number: 003081)186. To make Ptc1LacZ/+ mice, a targeting vector, KO1, containing 
sequence encoding nuclear localized beta-galactosidase (LacZ), neomycin 
resistance gene, mouse protamine 1 (mP1) intron, and a polyadenylation site was 
electroporated into 129-derived R1 embryonic stem (ES) cells. Correctly targeted ES 
cells were injected into C57BL/6 blastocysts. The resulting chimeric male mice were 
then mated to B6D2F1 females and backcrossed onto C57BL/6. This strain is also 
segregating the coat color allele dilute (Myo5ad). 
Ptc2LacZ/+ mice were made by Deltagen Inc. (Ptch2tm1Dgen/J, Jackson stock 
number: 005827)187. The construct insert is reported to be "Lac0-SA-IRES-LacZ-
Neo555G/Kan." These mice are maintained on C57BL/6 background. 
ShhEGFP/+ mice were made by Clifford Tabin. (B6.Cg-Shhtm1(EGFP/cre)Cjt/J, 
Jackson stock number: 005622 )91 To make the ShhEGFP/+ mice, a targeting vector 
containing a fusion product involving Enhanced Green Fluorescent Protein (EGFP) 
and Cre recombinase was inserted at the ATG of Shh and disrupted the sequence 
encoding the first 12 amino acids. The construct was electroporated into 
129S6/SvEv-derived TC-1 embryonic stem (ES) cells. Correctly targeted ES cells 
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were injected into recipient blastocysts. The resulting chimeric animals were crossed 
to C57BL/6 mice and are maintained on this background.91 
LysMcre/cre mice were made by Irmgard Foerster. (B6.129P2-Lyz2tm1(cre)Ifo/J, 
Jackson stock number: 004781)253. To make the LysMcre/cre mice, a targeting vector 
containing a FRT-flanked neomycin resistance gene, herpes simplex virus thymidine 
kinase genes and NLS (nuclear localization signal) -Cre cDNA, was inserted into the 
endogenous ATG-start site within exon 1 of the Lyzs gene. The construct was 
electroporated into 129P2/OlaHsd-derived E14.1 embryonic stem (ES) cells. 
Correctly targeted ES cells were transiently transfected with a Flp expression vector 
for the purpose of removing the selectable marker cassette. ES cells that had 
successfully undergone Flp recombination were injected in blastocysts. These mice 
are maintained on a C57Bl6/J background.  
Smoflox/flox mice were made by Andrew McMahon. (Smotm2AMC/J, Jackson 
stock number: 004526 )252. To make these mice, a loxP site flanked targeting vector 
containing a 400bp fragment of exon 1 and an FRT-flanked neomycin resistance 
gene was utilized in the construction of this mutant. This construct was 
electroporated into 129X1/SvJ derived AV3 embryonic stem (ES) cells. Correctly 
targeted ES cells were injected into C57BL/6J blastocysts. The resulting male 
chimeric animals were crossed to Swiss Webster females. These mice are 
maintained by intercrossing homozygous flox littermates. 
R26RYFP/YFP mice were made by Frank Costantini. (B6.129X1-
Gt(ROSA)26Sortm1(EYFP)Cos/J, Jackson stock number:00). To make these mice, a 
targeting vector was designed to contain the Enhanced Yellow Fluorescent Protein 
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gene (from the pEYFP-N1 plasmid, Clonetech) downstream of a loxP-flanked stop 
sequence (neomycin resistance gene and a trimer of the SV40 polyadenylation 
sequence). This entire construct was inserted into the Gt(ROSA)26Sor locus via 
electroporation of 129X1/SvJ-derived JM-1 embryonic stem (ES) cells. Correctly 
targeted ES cells were microinjected in C57BL/6J blastocysts. Chimeric male Y8-8 
was bred to a C57BL/6J female mouse. Mutant male progeny were backcrossed to 
C57BL/6J for 6 generations and then made homozygous. These mice are 
maintained by intercrossing homozygous R26R littermates.  
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